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Abstract 
Stroke and diabetes are relatively common conditions and have a huge impact on society’s burden of 
illness; over 400 million people around the world live with diabetes and 15 million have a stroke 
every year. Estimates on the disability-adjusted life years lost amount to 68 million due to diabetes 
and 120 million due to stroke annually. This burden to the individual and to society is neither 
ignorable nor possible to let escalate. 
With a very long history of diagnosis, continuous development of treatments, and extensive research 
on their effects (>287 thousand articles in PubMed with stroke and/or diabetes in the title), it could 
be expected that the highest quality of stroke and diabetes care delivery have spread across all 
groups of patients, no matter demographic profile, socioeconomic situation, or geographical area of 
residence. The aim of this thesis is to explore whether Swedish healthcare, which is universal and tax-
funded, is characterized by health inequities or not, with regards to stroke and diabetes care 
delivery. 
To enable extensive analysis on what patient characteristics that may play a role in regaining health 
after diagnosis and to what extent, registry data from several local, regional and national sources 
were linked on patient level. Data included administrative data (from regional databases), disease-
specific outcome and process markers on the entire chain of care (the Swedish Stroke Register and 
the National Diabetes Register respectively), demographic, socioeconomic and geographic 
information (Statistics Sweden), data on social insurance (the Swedish Social Insurance Agency), and 
data on municipal care such as special housing and home-help services (the National Board of Health 
and Welfare). These data were all part of the Sveus databases. All studies comprised analysis via 
multivariate regressions on health outcomes, resource use, and/or care process. 
There are differences in health regained and healthcare received. Women with ischemic stroke were 
found to have lower function (approximated modified Rankin Scale) one year after stroke whilst a 
larger proportion of women survived the first year compared to men. Inpatient care received 
(regional financing) was lower for female stroke patients whilst proportion of patients staying in 
special housing (municipal financing) was higher during the year prior to and the year after stroke. 
Women with Type 1 Diabetes had worse blood glucose control compared to men. For Type 2 
Diabetes, women had better blood glucose control compared to men, but higher levels of LDL 
cholesterol. Younger individuals typically showed worse blood glucose control than older for both 
Type 1 Diabetes and Type 2 Diabetes. 
The socioeconomic situation of individuals afflicted with stroke and/or diabetes also seems to play a 
role regarding health outcomes achieved as well as care process and healthcare resources received; 
high educational level (>12 years) was a significant predictor for better blood glucose control in both 
Type 1 and Type 2 Diabetes. High educational level was also a significant positive predictor for 
survival first year after stroke and functional status first year after ischemic stroke (data not 
presented in research papers). 
There is also a geographic gradient in Swedish stroke care, where a few hospitals achieve significantly 
better health outcomes than others and a few achieve significantly worse (adjusted for differences in 
patient characteristics). Some hospitals showed significantly higher levels of resource use whilst 
other showed significantly lower levels. No clear pattern emerged regarding the included hospitals’ 
relationship between health outcomes achieved and resources invested. 
Studying health equity in Swedish stroke and diabetes care delivery, within the five studies included 
in this thesis, demonstrates that there are health inequities. Stroke and diabetes have been known 
and diagnosed in medicine for a long time and still, different groups of people receive different 
amount of support for their condition relative to their needs, leading to significant differences in 
health and health-related quality of life. 
To change the situation, there is work that needs to be done by the policy makers, the payers and 
the care providing organizations. Policy makers need to integrate health equity as part of all relevant 
policy development, as it is also a prioritized goal according to Swedish law. Payers (of hospital care, 
special housing, pharmaceutical drugs) can start adjusting their incentive models at hand towards 
providers, based on dimensions of health equity. Providers must then act to raise awareness on 
which patients are at particularly high risk of low health outcomes.  
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1. Introduction 
The United Nations (UN), the World Health Organization (WHO) and the European Union (EU) 
declare that equity in healthcare is key [1, 2]. The UN declaration of human rights states that a state 
is obliged to ensure that healthcare is accessible to all, and especially for marginalized and vulnerable 
groups [3]. Equity in Swedish healthcare is regulated by the Healthcare Act [4], which, together with 
the universal, tax-subsidized, access to healthcare make health equity expected in the Swedish 
context. 
Reading the first paragraph above might give the impression that health equity or equity in general is 
a straight-forward topic, which would be a significant exaggeration. And perhaps that is a reason for 
this thesis’ existence; health inequity is a complex concept and comprises multiple perspectives, 
widely different and sometimes contradictive, depending on the dimension studied. Extensive 
research has been performed on the topic (see Table 1 and Table 2). Linking the studies to the 
theoretical foundation of health equity is however somewhat rare. 
The WHO has highlighted four non-communicable diseases (NCD) that are particularly heavy burdens 
to society (cardiovascular diseases including stroke, diabetes mellitus, pulmonary disease and 
cancer), paired with four risk factors that are modifiable and hence possible for the individual person 
to impact (tobacco use, unhealthy diet, physical inactivity and harmful alcohol consumption) [5]. 
Actions against these NCDs are core parts of the WHO Global Action Plan on NCDs [6]. 
This thesis is a study of health equity with two conditions out of the four mentioned above as 
examples; stroke (ischemic and intracerebral hemorrhage) and diabetes mellitus (Type 1 and Type 2). 
Stroke and diabetes are both important comorbidities to one another, and diabetes is also a risk 
factor for stroke. They can both end up being chronic conditions depending on how well the stroke 
patient is rehabilitated and how well her activity abilities and functions are recovered. To be able to 
study health equity in Swedish healthcare on a more general level it is advantageous to investigate 
pathways regarding both the stroke patient and the diabetes patient. Studying care related to stroke 
and diabetes enlightens us on different aspects of care; the two conditions afflict patients with 
different baseline characteristics and health profile, treatment of the two conditions demand 
resources in separate domains of the healthcare system, and different types of resources and 
procedures are required during treatment. Thus, studying health equity in the healthcare system is 
more probable to be valid if evaluating equity within both stroke care and diabetes care (which may 
sometimes overlap) than one of them alone. 
It has not been possible to discuss more general features of health equity concerning stroke and 
diabetes care delivery within each separate research paper included in the thesis. The thesis’ sections 
treating health equity is my chance to dig deeper and connect empirical evidence to previously 
developed theories, and to initiate a discussion on today’s situation as well as on desired policy 
implications. 
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Figure 1. Stroke and diabetes incidences in Sweden 2013-2017 according to the national quality 
registries. Data from the Swedish Stroke Register [7], the National Diabetes Register [7] and Statistics 
Sweden [8]. 
 
 
 
Figure 2. Number of new studies per year treating health equity, from 1970 until today. Based on 
availability on PubMed using search query including equity/equality/inequity/inequality in the 
abstract and/or title. Total refers to all articles available with ”study” or ”studying” in title and/or 
abstract. 
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1.1 Health equity – what, why and how? 
There might be concerns regarding the reasons for assessing the degree of health equity in society. 
This is probably not the case for readers with a fundamentally egalitarian point of view, i.e. who 
believe that all individuals – no matter what origin, social status, sex, education or income – are 
equal in terms of the value of their needs [9]. Some may however think that health equity is not a 
prioritized goal in itself. Still, these readers probably have an interest in understanding how the 
distribution of health and healthcare appears across society’s population. But as Sen argues [10], all 
people – no matter their philosophical or political view – do have some particular dimensions which 
they think should be equal to everyone, such as equal rights or equal access, or equal opportunities. 
In our modern society, the distribution of health would probably be practically possible to control, 
with highly sophisticated methods to track and map, to ease and to heal. The distribution of health is 
not to be confused with the distribution of wealth; redistribution of health may not actually require 
redistributing wealth but could instead be more a question of what the optimal allocation of 
resources is (e.g. preventative measures rather than reactive measures) or what a more efficient 
organization of care could look like. 
It is worth highlighting the difference between equality and equity in this context. Equality is a 
descriptive concept with objective facts relating to a certain situation e.g. the amount of outpatient 
visits per capita for different groups. Equity, on the other hand, adds the perspective of potential 
justification or absence of justification for such objective facts; is the difference in outpatient visits 
per capita adequate or not? Health equity can be defined as the absence of systematic disparities in 
health between different groups defined by their differing social advantages in society, as proposed 
by Braveman and Gruskin [11], or the absence of unwarranted and avoidable gaps in health between 
groups with different levels of privilege, e.g. demographic, socioeconomic or geographic [12]. The 
purpose of this thesis is to, as transparent as possible based on the research performed, show how 
today’s situation appear with regards to the distribution of health and healthcare after stroke and/or 
diabetes diagnosis for different groups in society. 
In this thesis, health equity in Swedish stroke and diabetes care delivery is studied in terms of the 
presence of sociodemographic determinants and to what extent these may be related to achieved 
health outcomes and received care. As Harvard professor and Nobel laureate Amartya Sen points 
out, the classification of individuals into groups can be made to point out different diversification, 
which will enlighten us regarding certain inequities but not others [10]. In this thesis I have used 
traditional ways of classifying individuals into groups to study equity between these groups, for 
example based on sex or educational level. Indicators used for assessing health equity and comparing 
results after stroke or diabetes care include health outcomes, levels of resources and degree of 
different processes received, and can be found in Table 6.  
 
1.1.1 Health equity and its definition(s) within this thesis 
World Health Organization presents four overarching dimensions to equity in terms of differences 
between groups; demographic, social, economic, and geographic [13]. Several attempts to define 
health equity have been made in the scientific literature; as the subject has a philosophical nature 
rather than an objective, e.g. medical or physiological one, one needs to understand the rationale 
behind equity to be able to judge whether there are inequities and whether these are unjust. 
Equal opportunities to good health among the general population implicitly assume the same 
opportunities and access to care in order to achieve health outcomes in line with the rest of the 
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population, regardless of differences in e.g. sex, origin and socioeconomic status. Consequently, any 
unwarranted health difference related to such factors should be considered unjust. Whitehead [14] 
argues that health inequity is the same as avoidable and unjust health differences, i.e. the 
individual’s belonging to a certain subgroup of the population (e.g. sex) rendering1 a lower outcome 
with statistical significance when adjusting for other selected explanatory factors of relevance, is to 
be seen as a health inequity. Braveman [15] follows that line and states that health equity should be 
defined as the absence of systematic disparities between the groups (defined by differences in social 
advantages), and that the level of health within the most privileged group in society could be 
observed as the minimum level of health for the whole population at a later point in time. However, 
health inequities within some European countries (e.g. England and Wales) have not only been 
present for quite a while; they have also widened during the last decades [16]. 
If health equity is the absence of systematic differences in health between groups of different 
advantages, then health equity must also be equivalent to absence of systematic differences in social 
determinants of health (systematic differences in social determinants of health imply differences in 
health, given the fact that they are “determinants”), i.e. there should be no social determinants of 
health in a society characterized by true health equity. In free societies, inhabitants tend to specialize 
within different tasks which demand varying levels of theoretical education. Hence, it is natural with 
varying levels of education, and the fact that people have different levels of theoretical education 
cannot possibly be a warranted, just, or fair explanation to differences in achieved health outcomes. 
Health equity could in that sense also be considered a matter of social justice. 
Given that achieved health outcomes to a certain extent depend on the amount and type of 
resources invested in treatment, it is necessary to also highlight the resource consumption when 
evaluating health equity in a population. Furthermore, as some explanatory factors can be 
considered to have a motivated (warranted) clinical effect on the health outcome studied (e.g. 
reduced consciousness upon arrival at emergency unit could be considered justified to affect the 
likelihood of survival and return to daily activities) and some explanatory factors cannot be 
considered a justifiable effect on the health outcome studied (e.g. the patient’s sex as the reason for 
increased likelihood of good activity ability after stroke), it is important to distinguish them in the 
discussion on equity and its influencing factors. To complicate things, the reduced consciousness at 
arrival may be due to the actual stroke severity at onset, but it may as well be due to modifiable 
factors dependent on e.g. the patient’s living situation. 
Within this thesis, stroke and diabetes care delivery is studied from the perspective of health 
outcomes achieved and the resources invested as well as the care processes leveraged to achieve 
these outcomes. The outcomes of a patient’s treatment have its base in several separate elements 
regarding what is generally denominated the determinants of health (see Figure 3). I have tried to 
distinguish between gradients within health equity on three different dimensions: demography, 
socioeconomics and geography. 
The demographic gradient includes the effect that may come from a patient’s sex or age on the 
treatment pathways or treatment results. The socioeconomic gradient relates to differences in 
health outcomes or healthcare consumption that are associated with the belonging in a group with 
similar characteristics in terms of e.g. educational level or income level. The geographic gradient 
refers to whether a patient’s geographical residence correlate with the health achieved or healthcare 
                                                          
1 Given that the studies within this thesis are retrospective, observational registry studies, it is hard to tell whether a 
causality or only a correlation is at hand. 
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received. Previous research on these dimensions of health equity in a Swedish setting, regarding 
stroke and diabetes care delivery, is presented in Table 1 and Table 2 respectively. 
 
1.1.2 Theoretical foundation 
There are several theories developed to understand and assess equity or equality. In general, the 
literature on the subject treats inequity or inequality, i.e. the difference between groups, rather than 
treating how equal the levels relating to a given indicator are. To better understand the distribution 
of health in society, it can be valuable to have a look at the distribution of other parameters that in 
general have a close association with health levels and development of health, such as social and 
economic welfare. 
Theories for understanding and assessing inequity in general 
Many of the theories published include health under a broader welfare category. It makes sense to 
do so, but to understand how health inequity arises and is reinforced, methods focused on assessing 
inequity in health are needed. The reason for this is merely that health does not have the same 
properties as welfare in terms of e.g. possibility to redistribute. Temkin [17] discusses several aspects 
of inequity of which I have selected those I find best suited for discussing inequities in health; 
1. Relative versus absolute differences. In the context of treatment outcomes, the relative 
comparison is generally the most common, e.g. comparisons versus the average or versus other 
individuals or units. One exception to this would be e.g. adherence to guidelines which often refer to 
absolute levels in terms of blood glucose or systolic blood pressure. If the comparison is relative, it is 
still a question whether the individual level for a patient (of body function, of specialized 
rehabilitation, or of an expensive but effective treatment intervention) should be compared to the 
average or to the level of the best-off patient/group of patients. 
2. The individual’s responsibility of her own health. The discussion on genomic heritage, social 
effects and the informed choice of the individual is complex. The (assumed to be) informed decision 
on e.g. smoking or physical activity may have significant consequences for the individual patient’s 
prognosis to live a well-functioning, healthy and perhaps long life. 
3. Maximin principle of justice or equality. Defined by Rawls [18] (as the difference principle) and 
developed by Temkin [17], the maximin principle of justice states that how well a system delivers 
depends on how well the worst-off group fares “with respect to inequality” [17]. Applied in practice, 
this principle would imply that a healthcare system with the apparent mission to deliver welfare to 
all, including the best off and the worst off, is at its best (and relatively better than other systems, 
e.g. other regions’ or countries’) when the worst-off group is well taken care of. 
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Selected framework focused on health equity 
There is extensive research literature on the topic of health equity and determinants of health. 
Several elements influence the existence of any (systematic) differences in health outcomes or 
healthcare consumption; based on a conceptual framework developed by Burström [19], the 
pathway can be divided into six high-level steps. These are, with some modification, presented in 
Figure 3. 
 
Figure 3. Conceptual framework for the arising of inequity in health and healthcare. Adopted from 
Burström [19]. 
There are several dimensions to the emergence of health equity, and the degree of change over each 
of these steps – possibly to be regarded as a multiplier – determines the different levels that can be 
observed in the final steps; healthcare delivery and consumption, and health outcomes. Where in 
this chain of events an individual’s health is especially affected may also vary on individual level. The 
scope of this thesis includes primarily assessments of the last two steps and aims at illustrating how 
the determinants of health – the first step – can explain the gradients of any differences to be 
observed regarding healthcare delivery and consumption (resource use as well as care process) and 
health outcomes. There is also a dimension of quality of care in the link between healthcare delivery 
and health outcome, i.e. how much good is done with the resources at hand. 
In addition to understanding the key output – health outcomes – it is of importance to also 
understand and quantify the resource side of it; different groups of patients demand different levels 
of resources to achieve the same levels of health as the “healthiest” group. It may however be 
considered challenging, if not impossible, to point out where to draw the line on when the marginal 
effect per invested Swedish krona is no longer feasible to pay for. 
 
General indicators of inequity 
There are some general indicators extensively used in the literature to measure the distribution of 
welfare in a society. These indicators are not often applied to specific cases such as stroke or 
diabetes care delivery. 
The Gini index (introduced by statistician and sociologist Corrado Gini in 1914 [20] and to a broader 
English speaking audience in 1921 [21]) is a measure of dispersion and relative inequality, initially 
developed to study the inequality of income and welfare. Its constitution is illustrated in Figure 4, 
where the y-axis shows the cumulative share of the good or service – e.g. health-related quality of 
life – whereas the x-axis shows the cumulative share of individuals with a given attribute – e.g. 
income – ranked from lowest to highest (lowest x is the individual with the lowest income). The 45-
degree line represents a situation where health-related quality of life is equally distributed across the 
population, i.e. all individuals, no matter their income, contribute with an equal share of health-
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related quality of life. The grey line – the Lorenz curve – represents an example situation where 
health-related quality of life is unequally distributed among the individuals studied. The area under 
the line of perfect equality and above the Lorenz curve (the area of concentration) tells us that 
individuals with relatively lower income have generally lower health-related quality of life. If the 
Lorenz curve was situated above the line of perfect equality the relationship would have been the 
opposite, i.e. the individuals with relatively lower income would be generally better off with regards 
to health-related quality of life. 
 
Figure 4. Illustration of the Gini index; the line of perfect equality and the Lorenz curve. 
This general measure is often used for high-level comparisons, e.g. between countries. However, 
comparisons have also been performed on other dimensions and on more regional level, e.g. to 
study healthcare access across different geographical areas [22]. There are also examples on putting 
the Gini index in relation to disease-specific indicators; Burns and colleagues found that there was a 
significant positive relationship between the Gini index and the incidence rate of schizophrenia [23], 
i.e. higher inequality was associated with higher risk of schizophrenia. 
There are additional measures such as the decile dispersion ratio (indicates relative inequality, 
calculated by best-off decile relative to worst-off decile [24]), the Hoover index (also known as the 
Robin Hood index, Schutz index or Pietra ratio; shows the proportion of distributed wealth to be 
redistributed in order to achieve perfect equality [25]) and the Atkinson index (presents the 
proportion of a society’s income that needs to be given up to reach a state of higher income equality, 
and depends on a given input value on society’s aversion of inequality [25]). These indicators will not 
be further discussed in this thesis but could potentially be applied to received care or achieved health 
outcomes after a performed intervention as well as to income and welfare. There are, however, 
challenges with applying a theory for distribution of wealth to distribution of health, as the latter 
tend to be somewhat more inert. One notable critique of these general measures is also that they do 
not account for changes in population volume – e.g. an increase in the absolute number of people in 
the worst-off group should possibly be viewed as an increase in inequality (at least not a decrease), 
but according to the Gini index the degree of inequality thereby decreases [26]. The challenge in an 
international setting is that definitions tend to vary somewhat across borders and therefore one 
needs to be cautious when performing such comparisons. 
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1.1.3 Health equity in the Swedish healthcare system 
Together with other Nordic countries, Sweden is often referred to as a country with a highly 
developed welfare system and ability to equalize the distribution of good health among its 
population [16]. Stated in Swedish law, quality of care shall be independent of a patient’s 
background, health profile and sociodemographic characteristics, and healthcare delivery should be 
executed in accordance with individuals’ needs for good health [4]. This statement is in line with the 
concept of horizontal equity – that equal needs should be reflected in equal healthcare access – as 
well as with vertical equity – that different needs should be reflected in adequately different 
healthcare access [27, 28]. Thus, there should be no unwarranted differences in delivered care 
dependent on differences in e.g. sociodemographic patient characteristics. These explicit law 
statements are closely related to the overall purpose with the studies within this thesis, which is to 
determine whether Swedish healthcare (exemplified by stroke and diabetes) could be viewed as 
characterized by health equity, and whether there are sociodemographic or geographic drivers to 
differences. 
For any welfare-focused state such as Sweden, aspiring to proffer equity across all categories of 
services offered (including healthcare), the explicit goal is and probably will remain: higher degree of 
health equity. Notwithstanding the rise of the welfare state, health inequities have not been 
eradicated and their magnitude do not seem to become smaller over time. The Swedish situation is 
an illustrating example, anecdotally exemplified by the studies of stroke and diabetes patients 
included in this thesis. Sweden is generally known as the typical welfare state, with a relatively low 
Gini index and ranked as being in the higher span in terms of decommodification rates [29] as well as 
social spending per capita [30]. According to Mackenbach [31], Sweden shows a low relative index of 
inequality regarding education (for both sexes) and its impact on mortality. Furthermore, Sweden 
stands out as having low absolute differences in mortality within the population – only the Basque 
region in Spain beats Sweden regarding lowest inequalities in average rate of death from any cause. 
Based on e.g. the Gini index in Sweden relative to other countries, it could be suggested that any 
differences observed between sociodemographic and geographically distributed groups for the 
Swedish stroke and diabetes patient populations may be of higher proportions when applied to other 
countries in the world. In other words, if there are significant disparities in equitable Sweden, 
disparities may be of higher magnitude in other countries. Such a speculative hypothesis would also 
be an argument to why studying health equity in Sweden should be regarded as highly relevant, as 
health equity may not be higher in any other country in the world. Interestingly though, Mackenbach 
[31] did not observe any pattern of systematically smaller differences in health in populations of 
countries in northern Europe (characterized by more generous welfare policies) compared to other 
European countries [31]. These findings were based on self-assessed health and the results were not 
stratified on single conditions such as stroke or diabetes. Whether there is no pattern of 
systematically smaller differences in e.g. Sweden for the patient populations with these specific 
conditions is possible but yet to be assessed. 
 
 
  
21 
 
1.2 Stroke 
Stroke is an acute condition with risk of severe sequels, particularly if not treated. It is the third 
leading cause of death in the world, and the third largest cause of disability, with 6.2 million deaths 
and 120 million DALYs yearly estimated for 2017 (132 million DALYs if including SAH) [32, 33]. 
 
1.2.1 Pathophysiology 
Stroke is defined as rapidly developing clinical signs of focal (or global) disturbance of cerebral 
function, with symptoms lasting at least 24 hours or leading to death, with no apparent cause other 
than of vascular origin [34]. A stroke can be due to either an occlusion of a blood vessel due to 
thrombosis or emboli, hereafter referred to as ischemic stroke (IS), or a rupture of the vessel, i.e. a 
hemorrhagic stroke (intracerebral or subarachnoid hemorrhage) [35].  
 
1.2.2 Epidemiology 
During the last couple of years stroke has afflicted approximately 21,000-26,000 individuals per year 
in Sweden [7, 36], corresponding to an incidence rate of 0.3% of the Swedish population above the 
age of 18 years [8]. Approximately 75% are first-ever strokes [7]. Of all stroke cases in Sweden, 
approximately 85% are ischemic, 10% are intracerebral hemorrhages (ICH), and 5% are subarachnoid 
hemorrhages. More than 80% of stroke cases affect individuals over 65 years of age. Men are 
predominantly afflicted in younger ages whilst the proportion of women is larger in higher ages [7, 
37]. In the study populations for this thesis, only intracerebral hemorrhages and ischemic strokes are 
included. 
 
Stroke incidence in Sweden has decreased by 15% between 2010 and 2017 overall (although not for 
all age groups) [7]. There is however concern that the global incidence of and mortality from 
ischemic stroke will take an upturn for the first time in more than 40 years, possibly due to the 
increasing prevalence of obesity [32, 38]. There is also evidence that stroke incidence has increased 
in younger age groups over the last couple of years [39]. Risk factors for stroke include hypertension 
and atrial fibrillation [40]. For stroke as well as for diabetes, four major lifestyle factors have been 
raised by the WHO; physical activity, diet, tobacco and alcohol use [5]. 
 
Stroke morbidity and mortality is a costly burden to the individual as well as to society. Impairments 
after stroke include both physical and mental dimensions. In addition to major suffering for patients 
and their close ones, stroke implies high monetary costs for society, short-term and long-term. Total 
annual costs due to stroke in Sweden have been estimated to SEK 18 billion [41]. 
 
The National Board of Health and Welfare's report on Swedish stroke care states that it could be 
considered equal on several areas, based on age, sex and geography. At the same time, regional 
differences in waiting times as well as differences between sexes and socioeconomic groups 
regarding post-stroke drug treatment are pointed out [42]. Also, regional differences for stroke 
patients in terms of resource utilization and health outcomes have been described [43]. 
 
1.2.3 Treatment of stroke 
There are several highly recommended treatment interventions for stroke patients; acute 
pharmacological and interventional treatments in the acute phase, physical and cognitive 
rehabilitation in the post-acute phase, and pharmacological preventive treatments in the acute as 
well as the post-acute phase. 
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Early acute reperfusion treatment of ischemic stroke includes thrombolysis and thrombectomy. Both 
have the purpose of removing the thrombosis or emboli causing the ischemia, and thus allow for 
reperfusion of the brain tissue. Thrombolysis is an intravenous treatment where a pharmaceutical 
drug is introduced into the blood stream to dissolve the blood clots which would otherwise cause 
tissue ischemia. It has been proven to be effective under certain time intervals, which have emerged 
with continuously updated scientific evidence [44-47]. Treatment with thrombolysis also induces risk 
of side-effects as it has a systemic effect on the entire body’s coagulation process. Thrombectomy is 
a catheter-based interventional method to remove blood clots from a blood vessel. It has gained an 
increase in penetration rate as recent scientific evidence has demonstrated its contribution to 
significantly improved clinical outcomes [48]. A study of thrombectomy in terms of costs and benefits 
has been performed on Swedish data and deemed the treatment intervention cost-saving from a 
societal perspective [49]. It is a relatively new treatment intervention and in need of highly 
competent and experienced neuro interventionists, and so far there is an apparent geographical 
gradient in the Swedish system’s offering of it [7, 50] (Figure 5). 
 
 
 
Figure 5. Geography and thrombectomy: number of interventions per 100,000 inhabitants, split by 
greater healthcare region. Sweden is divided into six greater healthcare regions which shall all be 
capable of offering advanced care; not to be confused with Sweden’s 21 regions or county councils 
which tax their inhabitants and fund healthcare for individuals living in their geographic area [51]. 
Data available via the Swedish Stroke register [7] and the National register for endovascular 
treatment of stroke [50]. 
 
Hemicraniectomy is a procedure which includes removing parts of the scull bone to release pressure 
on the brain due to the stroke. It is relatively uncommon, and performed in less than 0.2% of the 
cases in Sweden [7]. In close relation to having had an ischemic stroke, endarterectomy – removal of 
stenotic tissue in the carotid arteries – has been shown to be associated with lower risk of stroke 
recurrence [52, 53]. 
 
The National Board of Health and Welfare continuously updates national guidelines for treatment of 
stroke. These guidelines consider the care process of the stroke patient and include 110 
recommendations in the 2018 version. Recommendations include three types; actions to take 
(graded on a scale 1-10), actions to take if evaluated within a research project, and actions not to 
take. Actions with the highest degree of priority (“priority 1”) include [54]: 
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• Structured process for acute care including preparations for thrombolysis and 
thrombectomy if needed 
• Offering thrombolysis within 4.5 hours from stroke onset (first symptom) for patients with 
acute ischemic stroke 
• Offering thrombectomy for patients with acute ischemic stroke and occlusion of the major 
front vessels of the brain 
• Using angiography in direct relation to computed tomography (CT) to identify any occlusion 
in the major front vessels of the brain in patients with acute ischemic stroke, to prepare for 
thrombectomy if needed 
• Offering treatment at specialized stroke unit in immediate relation to hospital arrival for 
patients with suspected stroke 
• Offering treatment at specialized stroke unit for patients with confirmed stroke 
• Offering a doctor’s examination for multimorbidity patients who stay at special housing or 
receive home care and who are at risk of having a stroke 
• Offering ultra sound for patients with ischemic stroke for whom surgical intervention in the 
carotid(s) (endarterectomy) may be in question 
• Offering endarterectomy within 14 days after stroke for patients with carotid stenosis 
symptoms 
• Offering decompressive hemicraniectomy in the acute phase to patients with expansive 
ischemic stroke 
• Examining ability to swallow in patients who have had a stroke 
• Using CT to confirm SAH in individuals with severe headache and with less than six hours 
from onset 
• Using lumbar puncture to confirm SAH in individuals with severe headache, with less than six 
hours from onset, and whom have undergone CT 
 
A significant proportion of the strongly recommended actions (4 out of 13 priority-1 
recommendations) relates to treatment with thrombolysis or thrombectomy or preparations to 
enable such treatment. None of them regards long-term rehabilitation. In addition to the guidelines, 
the National Board of Health and Welfare has published 35 indicators (including target levels for 
selected ones), that are designed to reflect adherence to the guidelines over the care process. 
Another highly important measure to mitigate risk of stroke recurrence is pharmaceutical drugs, and 
the pharmacological need depends on stroke subtype, i.e. ischemic versus hemorrhagic. After 
ischemic stroke, the risk of stroke recurrence is reduced with antithrombotic drugs that impact the 
coagulation process and risk of blood clotting. If no atrial fibrillation is present, an antiplatelet such 
as aspirin and/or clopidogrel is used. In patients with embolic stroke anticoagulants are used. 
Antivitamin K used to be the major secondary prophylactic treatment option but there are now 
several non-vitamin K anticoagulant drugs available which have increased in penetration during the 
last couple of years. In addition, statins, antihypertensive medication and, if needed, antiarrhythmic 
treatment are strongly associated with outcomes in terms of stroke recurrence and vascular death of 
other origin [40]. In hemorrhagic stroke, antihypertensive treatment is recommended [55]. 
Stroke unit care has been shown to improve outcome. Patients treated in stroke units are more likely 
to be alive, independent, and living at home one year after the stroke, regardless of age, sex, or type 
of stroke [56-59]. Major parts of available literature and results from clinical trials are focused on the 
acute phase. The long-term outcomes for the individual as well as for society are however dependent 
also on specialized rehabilitation. 
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1.2.4 Stroke and mental comorbidity 
One percent of the global population receives a formal diagnosis of psychosis or schizophrenia, and 
the prevalence in Sweden is equivalent; the actual number of afflicted individuals is however 
expected to be significantly higher [60, 61]. These individuals generally consume more of healthcare 
resources than other patients; with worse somatic health, they are also more likely to develop 
comorbidity [62-65]. Somatic comorbidity also seems to be more common in women than in men for 
this group [66, 67], and the risk of cardiovascular disease increases after treatment with 
antipsychotic drugs [68, 69]. 
 
 
 
   
Figure 6. Number of new studies per year treating stroke and mental comorbidity, from 1990 until 
today. Based on availability on PubMed using search query including stroke and mental 
health/mental illness/mental comorbidity/mental ill health in the abstract and/or title. 
 
As seen in Figure 6 there seems to be an increasing awareness in the scientific community, but still 
unexpectedly low. The group of stroke patients with pre-stroke psychosis and/or schizophrenia – 
how they are treated in comparison to other stroke patients, and to what extent they regain health 
after stroke – is relatively unstudied. It has been shown that these patients have lower access to care 
and to some procedures, [70, 71] also within a universal healthcare system [72, 73]. Furthermore, 
these individuals receive less stroke rehabilitation [74]. Diagnosis of psychosis or schizophrenia may 
be considered as having higher specificity compared to other states of mental ill-health and has been 
shown to be associated with cerebrovascular disease [75]. The subgroup of stroke patients with 
previous psychosis and/or schizophrenia diagnosis was hence considered an adequate group of 
individuals to study in terms of comorbidity compared to other stroke patients. 
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1.3 Diabetes 
Diabetes mellitus is a group of chronic metabolic conditions with the common property of inability to 
maintain consistent blood glucose levels without treatment, which may lead to acute as well as 
chronic complications. To fulfill the WHO’s diagnostic criteria of diabetes mellitus, there has to be 
either a fasting glucose of >7.0 mmol/L or a blood glucose of >11.1 mmol/L at 2 hours after ingestion 
of 75 g of oral glucose (glucose tolerance test), or a level of glycated hemoglobin (HbA1c) of >6.5% 
[76]. 
 
Diabetes is the eighth leading cause of death from non-communicable disease (NCD) in the world 
(number 15 overall) and the ninth leading cause of disability (number six of NCDs), causing 1.4 million 
deaths and 68 million DALYs annually [32, 33]. It has been estimated that over 400 million individuals 
around the world live with diabetes [77]. Between 2007 and 2017 Type 2 Diabetes showed the 
largest relative increase in DALYs of all conditions defined by the WHO. In addition, rates of 
complication due to diabetes are on the rise; chronic kidney disease due to Type 2 Diabetes showed 
the second largest relative increase of all conditions defined by the WHO in terms of DALYs during 
2007-2017 [33]. 
 
1.3.1 Pathophysiology 
The main differentiation of diabetes mellitus is based on the pathologic process leading up to the 
inability to self-maintain consistent blood glucose levels, and the most common types are Type 1 
Diabetes (T1D) and Type 2 Diabetes (T2D). Both types result from several gene mutations in 
combination with environmental factors, and T2D is considered hereditary to a larger extent than 
T1D [78]. There are light variants of the condition, with impaired ability to keep blood glucose in the 
normal interval, referred to as impaired fasting glycemia and impaired glucose tolerance. These 
conditions can be an intermediary stage (“prediabetes”) prior to a clinical diagnosis of diabetes, and 
individuals with such a condition are at increased risk of complications compared to individuals with 
normal levels of fasting glucose [78, 79]. 
 
T1D arises when the pancreas fails to produce insulin needed to lower blood glucose by enabling 
glucose to enter the body’s cells, and it is due to an autoimmune reaction against the insulin-
producing beta cells of the pancreas. T2D originates from a combination of higher tolerance and 
lower secretion of insulin, and an increased hepatic production of glucose [79]. 
 
1.3.2 Epidemiology 
The prevalence of diabetes in Sweden has been estimated to a total of 4-5% for the two main types, 
and approximately 85-90% of diabetes patients suffer from T2D [80, 81]. The prevalence of impaired 
glucose intolerance, an indicator of developing T2D, is estimated to be twice the diabetes 
prevalence, i.e. 8-10%. For diabetes as well as for stroke, four lifestyle factors have been raised by 
the WHO as particularly important to address; physical inactivity, unhealthy diet, tobacco and alcohol 
consumption [5]. 
 
Increased rates of short-term and/or long-term complications of diabetes lead to increased need of 
care and resource utilization. Socioeconomics have been shown to play a role in the development of 
diabetes and diabetes care; low level of education or low income is associated with increased risk of 
T2D, and it is more common for low-income individuals not to reach treatment goals for HbA1c 
and/or blood lipids [81, 82]. 
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1.3.3 Treatment of diabetes 
Treatment of diabetes aims at keeping blood glucose homeostasis and thereby minimizing the risk of 
complications. Complications include vascular – microvascular (nephropathy, neuropathy and 
retinopathy) and macrovascular (cerebrovascular disease such as stroke and peripheral artery 
disease) – as well as nonvascular ones including skin changes and infections [79]. A key to successful 
treatment is continuous monitoring of the patient’s blood glucose levels, but also to monitor his/her 
health status in terms of risk factors for associated morbidity and to manage any complications.  
Individuals with T1D are dependent on continuous treatment with insulin injections, as about one 
third of individuals with T2D [78]. These are in general manually managed, but the penetration rates 
of automatic support with injections via insulin pumps are increasing [7]. T2D patients use other 
pharmaceutical agents such as metformin to lower the insulin resistance. Maintaining a healthy diet 
and physical activity are main components of a diabetes patient’s self-treatment. 
The National Board of Health and Welfare continuously updates national guidelines for treatment of 
diabetes. These guidelines include recommendations (approximately 140 in the 2018 version) of 
three types; actions to take (graded on a scale 1-10), actions to take if evaluated within a research 
project, and actions not to take. Actions with the highest degree of priority (“priority 1”) include [83]: 
• Offering intense statin treatment for individuals with diabetes at high risk of CVD 
• Offering antihypertensive treatment for individuals with diabetes and hypertension 
• Offering support to stop smoking for individuals with diabetes who smoke 
• Offering support to increase physical activity for individuals with T2D 
• Offering intense treatment for individuals with T1D to reach best blood glucose levels 
possible with regards to risk of hypoglycemia, reduced quality of life or other negative 
influences on the individual’s well-being 
• Offering intense treatment for individuals with recently diagnosed T2D and no known CVD to 
reach best blood glucose levels possible with regards to risk of hypoglycemia, significant 
weight gain, reduced quality of life, expected remaining life span and other morbidity 
• Offering annual examination of the urine concentration of albumin in individuals with 
diabetes 
• Offering fundus photography every third year for individuals with T2D who are not diagnosed 
with fundus disease 
• Offering systematic self-assessment of blood glucose levels for individuals treated with 
insulin injections 
• Offering metformin monotherapy for individuals with T2D given no intolerances or 
contraindications 
• Offering care from a multidisciplinary foot team for individuals with severe foot 
complications (e.g. wounds, infections or deformities) 
There are 21 indicators, with target levels for selected ones, that are designed to reflect adherence 
to the guidelines over the care process. 
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2. Perspectives on health equity in Swedish stroke and diabetes care delivery 
2.1 Previous research: Overview – scope, search and findings 
Previous research on the topic of health equity within stroke and diabetes care in a Swedish context 
has been reviewed. The search was performed in accordance with PRISMA guidelines [84]. Eligibility 
criteria for inclusion in the systematic review were: evaluation of health equity in stroke or diabetes 
patients with regards to health outcomes (e.g. mortality), resource use (e.g. inpatient care) or 
process (e.g. treatment intervention such as thrombolysis) as study outcome, based on Swedish 
registry data, published during 2000-2018 in a peer-reviewed journal available on PubMed. For 
inclusion in the final review, studies had to treat health equity based on differences in either 
demography (e.g. sex, age), social context (e.g. education, immigration, marital status), economics 
(income) or geography (regional variation). Studies regarding differences in incidence of the 
conditions only were excluded. Furthermore, international comparisons of outcomes have been 
excluded as the focus has been regional variations in Sweden specifically. The search string is 
specified in Appendix A. 
Health equity, as being a broad topic, was divided into categories based on what aspect of equity or 
inequity that was part of each study’s objective. The studies have been divided into three categories 
based on dimension of equity used, in line with the WHO [13]; demography, socioeconomics (merge 
of the WHO’s “social” and “economic” dimensions), and geography. If not explicitly stated in the 
article assessed, categorization was based on the perspectives presented in the article’s results 
section or based on expressed aim of the study. In total, 27 articles were assessed in full-text and 23 
of these were included in the qualitative synthesis. All data sources and outcomes studied have been 
named as stated in each article respectively. 
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Figure 7. PRISMA flow diagram for the literature review process. 
Of the included articles, 13 treated stroke and 10 related to diabetes care delivery. The major part of 
stroke articles treated either sex differences (five articles) or socioeconomic differences (seven 
articles), and the most common outcomes studied were survival or fatality/mortality. All articles 
applied adjustment of results to reflect differences in case mix between the compared groups, to a 
varying degree. Studies focused on either ischemic stroke only (five articles) or both ischemic and 
hemorrhagic stroke (eight articles). None of the retrieved full-text articles focused on hemorrhagic 
stroke only. 
Of the diabetes articles included in the review, six treated T1D, three articles treated T2D and one 
article treated diabetes as a general condition. The studies assessed association between outcomes 
and socioeconomic factors (seven articles) or sex (three articles). Most common outcomes studied 
were mortality (three articles) and glycemic control (three articles). Reviewing previous research on 
diabetes, it became clear that long-term follow-up is needed to study hard endpoints (e.g. mortality) 
or long-term disease impact (e.g. end-stage renal disease) as was the case in one of the articles 
(follow-up time in this study amounted to 19-36 years). The more common approach was to study 
intermediate outcomes such as glycemic control (HbA1c levels). 
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Table 1. Previous research on health equity in Swedish stroke care delivery. 
Title Authors Year Registry source(s) 
Primary outcome(s) 
(equity indicators) 
Health equity 
perspective 
Covariates /  
stratification 
Study population (incl 
sex distr and 
information on 
case/control) 
Sex differences in stroke 
care and outcome in the 
Swedish national quality 
register for stroke care 
Eriksson et 
al [85] 
2009 
Swedish Stroke 
Register (Riksstroke) 
Fatality, living situation, 
health status including 
depression, ADL, 
patient satisfaction 
Demography 
(sex) 
Sex, age 
24,633 stroke cases 
(12,350 men, 12,283 
women) 
Sex, diastolic blood 
pressure, and outcome 
after thrombolysis for 
ischemic stroke 
Nathanson 
et al [86] 
2014 
Södersjukhuset local 
stroke registry 
Functional status 
(modified Rankin Scale), 
mortality 
Demography 
(sex) 
Sex, age, diastolic 
blood pressure, 
comorbidity, 
medication and 
selected interaction 
terms 
355 patients (193 men, 
162 women) 
Education level and 
inequalities in stroke 
reperfusion therapy: 
observations in the 
Swedish stroke register 
Stecksén et 
al [87] 
2014 
Swedish Stroke 
Register (Riksstroke) 
Reperfusion treatment 
(thrombolysis and/or 
thrombectomy) 
Socioeconomics 
(education) 
Sex, age, education, 
living situation, ADL, 
comorbidity, smoking, 
antihypertensive 
agents. Stratification 
on hospital 
specialization. 
85,885 patients (50,166 
men, 35,719 women) 
Few sex differences in the 
use of drugs for secondary 
prevention after stroke: a 
nationwide observational 
study 
Sjölander et 
al [88] 
2012 
Swedish Stroke 
Register (Riksstroke) 
and Swedish 
Prescribed Drug 
Registry 
(Läkemedelsregistret) 
Prescribing, primary 
adherence (filling 
prescription first 4 
months after 
discharge), persistence 
(first 2 years after 
discharge) 
Demography 
(sex) 
Age, comorbidity, 
stroke severity, stroke 
unit care, statin 
treatment 
18,349 patients (9,331 
men, 9,018 women) 
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Reduced inequality in 
access to stroke unit care 
over time: a 15-year follow-
up of socioeconomic 
disparities in Sweden. 
Glader et al 
[89] 
2013 
Swedish Stroke 
Register (Riksstroke), 
Statistics Sweden 
(LISA, SCB) 
Stroke unit care 
Socioeconomics 
(education, 
income) 
Sex, age, education, 
income, living 
situation, ADL, stroke 
severity, stroke 
severity, year of stroke 
onset 
124,173 patients 
(77,535 men, 46,638 
women) 
Socioeconomic Inequalities 
in the Prescription of Oral 
Anticoagulants in Stroke 
Patients With Atrial 
Fibrillation 
Sjölander et 
al [90] 
2015 
Swedish Stroke 
Register (Riksstroke), 
Statistics Sweden 
(LISA, SCB), Swedish 
National Inpatient 
Register 
(Patientregistret) 
Prescription of any oral 
anticoagulant at 
discharge 
Socioeconomics 
(education, 
country of birth, 
income) 
Sex, age, country of 
birth, education, 
income, living 
situation, ADL, stroke 
severity, comorbidity, 
smoking 
12,033 patients (5,423 
men, 6,610 women) 
Socioeconomic factors’ 
effect on return to work 
after first stroke 
Glader et al 
[91] 
2016 
Swedish Stroke 
Register (Riksstroke), 
Statistics Sweden 
(LISA, SCB) 
Return to work 
(patient-reported) 
Socioeconomics 
(education, 
income) 
Sex, age, functional 
status (low mood, pain, 
ADL), 
income/education/ 
living situation/ 
country of birth, 
answering of 
questionnaire 
2,539 patients (1,594 
men, 945 women) 
Socioeconomic disparities 
in stroke case fatality - 
Observations from Riks-
Stroke, 
the Swedish stroke register 
Lindmark et 
al [92] 
2013 
Swedish Stroke 
Register (Riksstroke), 
Statistics Sweden 
(LISA, SCB), Swedish 
Cause of Death 
Register 
Case fatality (8-28 days, 
29 days-1 year after 
stroke respectively) 
Socioeconomics 
(education, 
income) 
Sex, age, education, 
income, country of 
birth, living situation, 
stroke severity, 
comorbidity, smoking, 
stroke subtype, 
medication, year of 
stroke onset 
60,105 patients (37,074 
men, 23,031 women) 
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Differences in 
cardiovascular risk factors 
and socioeconomic status 
do not explain the 
increased risk of death 
after a first stroke in 
diabetic patients: results 
from the Swedish Stroke 
Register 
Eriksson et 
al [93] 
2013 
Swedish Stroke 
Register (Riksstroke), 
Statistics Sweden 
(LISA, SCB) 
Survival, cause of death 
Socioeconomics 
(education, 
income) 
Sex, age, education, 
income, country of 
birth, living situation, 
ADL, diabetes 
diagnosis, other 
comorbidity, stroke 
severity, medication, 
smoking, stroke unit 
care, thrombolysis, 
year of stroke onset 
155,806 stroke patients 
(77,544 men, 78,262 
women); diabetes 
subcohort consisted of 
29,580 stroke patients 
(19.0% of study 
population) 
Life satisfaction in younger 
individuals after stroke: 
different predisposing 
factors among men and 
women 
Röding et al 
[94] 
2010 
Swedish Stroke 
Register (Riksstroke) 
Life satisfaction 
Demography 
(sex) 
Sex, age, living 
situation, comorbidity, 
functional status 
(including ADL), stroke 
unit care, smoking, 
working situation 
1,068 stroke patients 
(609 men, 411 women) 
Sex differences in 
management and outcome 
after stroke: a Swedish 
national perspective 
Glader et al 
[95] 
2003 
Swedish Stroke 
Register (Riksstroke) 
Case fatality, functional 
status, dependence on 
help, living situation 
Demography 
(sex) 
Sex, age, living 
situation, comorbidity, 
stroke severity, stroke 
unit care, stroke 
subtype 
19,547 stroke patients 
(9,881 men, 9,666 
women) 
Large variations in the use 
of oral anticoagulants in 
stroke patients with atrial 
fibrillation: a Swedish 
national perspective 
Glader et al 
[96] 
2004 
Swedish Stroke 
Register (Riksstroke) 
Prescription of oral 
anticoagulants 
Geography 
(regional 
variation) 
Sex, age, living 
situation pre and post 
stroke, functional 
status, comorbidity, 
stroke severity, stroke 
unit care, healthcare 
region 
18,276 stroke patients 
(the two subcohorts 
presented consisted of 
approximately 53% 
women each) 
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Sociodemographic factors 
are associated with 
utilization of statins after 
ischemic stroke/TIA - a 
cross sectional 
retrospective study 
Geary et al 
[97] 
2017 
National Swedish 
Prescribed Drug 
Register, Statistics 
Sweden national 
registers 
Dispensation of statins, 
dispensation of 
antihypertensive agents 
Socioeconomics 
(education, 
income, country 
of birth) 
Sex, age, education, 
income, country of 
birth 
24,312 stroke patients 
(the subcohort 
presented, alive 12 
months after stroke, 
consisted of 9,801 
men, 9,443 women) 
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Table 2. Previous research on health equity in Swedish diabetes care delivery. 
Title Authors Year Registry source(s) 
Primary outcome(s) 
(equity indicators) 
Health equity 
perspective 
Covariates /  
stratification 
Study population (incl 
sex distr and 
information on 
case/control) 
National Swedish study 
of immigrant children 
with type 1 diabetes 
showed impaired 
metabolic control after 
three years of 
treatment. 
Söderströ
m et al 
[98] 
2016 
Swediabkids 
(National quality 
registry for 
paediatric diabetes 
in Sweden), 
Statistics Sweden 
national registers 
Glycaemic control (HbA1c), 
frequency of hypoglycemia or 
ketoacidosis 
Socioeconomics 
(immigration) 
 Sex, BMI, insulin 
method and units, 
maternal marital status, 
mat. education level, 
mat. employment, mat. 
social welfare, housing 
2,627 diabetes 
patients; each patient 
born to immigrant 
parents matched by 
three children born to 
Swedish parents on 
sex, age and year of 
diabetes onset 
(diagnosis) 
Risk of hospitalization 
for type 2 diabetes in 
first- and second-
generation 
immigrants in Sweden: 
a nationwide follow-up 
study. 
Li et al 
[99] 
2013 
Swedish Hospital 
Discharge Register, 
Statistics Sweden 
national registers 
Risk of hospitalization for type 2 
diabetes (T2D) 
Socioeconomics 
(immigration) 
Immigrant status (first 
or second generation), 
sex, age, geographical 
region (one of Sweden’s 
three major cities, 
Southern Sweden, 
Northern Sweden), 
employment, 
comorbidity, family 
history of T2D 
hospitalization 
Entire national 
population 1964-2007 
Long-term detrimental 
consequences of the 
onset of type 1 diabetes 
on annual 
earnings--evidence 
from annual registry 
data in 1990-2005 
Steen 
Carlsson 
et al [100] 
2010 
Econ-DISS 
(Diabetes 
Incidence Study in 
Sweden) research 
database, Statistics 
Sweden national 
registers 
 Annual earnings (after diabetes 
onset) 
Socioeconomics 
(impact on 
income) 
Sex, age, living in urban 
area, employment, own 
and parental education 
 3,650 diabetes cases, 
14,629 controls 
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Age and gender 
differences in the 
impact of diabetes on 
the prevalence of 
ischemic heart disease: 
a population-based 
register study. 
Wiréhn et 
al [101] 
2008 
Care Data 
Warehouse in 
Östergötland 
(regional 
administrative 
database), Cause 
of Death Registry 
 Ischemic heart disease 
Demography 
(age, sex) 
 Sex, age, comorbidity 
10,364 diabetes cases, 
11,311 ischemic heart 
disease cases 
Marginal structural 
model to evaluate the 
joint effect of 
socioeconomic 
exposures 
on the risk of 
developing end-stage 
renal disease in 
patients with type 1 
diabetes: a longitudinal 
study based on data 
from the Swedish 
Childhood Diabetes  
Study Group 
Pazzagli et 
al [102] 
2017 
Swedish Childhood 
Diabetes Register, 
Swedish Renal 
Register, National 
Inpatient Register, 
Statistics Sweden 
and National 
Board of Health 
and Welfare 
national registers 
 Risk of end-stage renal disease 
Socioeconomics 
(unemploy-
ment, income 
support) 
Sex, age, own and 
parental education 
level, birth cohort 
4,034 diabetes 
patients 
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Impact of ethnicity on 
progress of glycaemic 
control in 131,935 
newly diagnosed 
patients with type 2 
diabetes: a nationwide 
observational study 
from the Swedish  
National Diabetes 
Register 
Rawshani 
et al [103] 
2015 
National Diabetes 
Register, National 
Board of Health 
and Welfare 
national registers 
Progress of glycaemic control  
Socioeconomics 
(country of 
birth) 
Sex, age, diabetes 
duration, BMI, smoking, 
previous CVD, physical 
activity, medication, 
income, education, 
eGFR 
131,935 diabetes 
patients  
Mortality in childhood-
onset type 1 diabetes: a 
population-based 
study. 
Dahlquist 
et al [104] 
2005 
Swedish Childhood 
Diabetes Register, 
Cause of Death 
Register 
Mortality (included but not 
limited to diabetes-related 
events) 
Demography 
(sex, age) 
Sex, age 
78 cases of fatal 
events in diabetes 
patients 
Association Between 
Socioeconomic Status 
and Mortality, 
Cardiovascular Disease, 
and Cancer in Patients 
With Type 2 Diabetes 
Rawshani 
et al [105] 
2016 
National Diabetes 
Register, National 
Inpatient Register, 
Cause of Death 
Register, Statistics 
Sweden national 
registers 
Mortality (all-cause, 
cardiovascular, diabetes-related, 
cancer) 
Socioeconomics 
(income, 
educational 
level, marital 
status, country 
of birth) 
Sex, age, diabetes 
duration, smoking, 
HbA1c, eGFR, 
treatment, BMI, 
albuminuria, 
comorbidity, income, 
education, marital 
status, country of birth 
217,364 diabetes 
patients 
Teenage girls with type 
1 diabetes have poorer 
metabolic control than 
boys and face more 
complications in early 
adulthood. 
Samuelsso
n et al 
[106] 
2016 
Swediabkids 
(National quality 
registry for 
paediatric diabetes 
in Sweden), 
National Diabetes 
Registry 
Glycaemic control (HbA1c) 
Demographic 
(sex) 
Sex, age, diabetes 
duration, smoking, BMI, 
physical activity 
4,239 diabetes 
patients  
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Impact of 
Socioeconomic Status 
on Cardiovascular 
Disease and Mortality 
in 24,947 Individuals 
With Type 1 Diabetes 
Rawshani 
et al [107] 
2015 
National Diabetes 
Register, Swedish 
Inpatient Registry, 
Causes of Death 
Registry, Statistics 
Sweden national 
registers 
Mortality, cardiovascular event 
Socioeconomics 
(marital status, 
income, 
education, 
country of 
birth) and 
demography 
(sex) 
Sex, age, diabetes 
duration, immigrant 
status, smoking, HbA1c, 
eGFR, physical activity, 
comorbidity, 
albuminuria, blood 
status, systolic blood 
pressure, marital status, 
income, education, 
country of birth 
24,947 diabetes 
patients 
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2.1.1 Demography 
Sex differences were studied in five of the articles treating stroke. In these articles, outcomes after 
stroke were either adjusted for sex as a covariate in multivariable regression or outcomes were 
stratified by sex.  
According to the stroke studies included in this review, sex differences in outcomes after stroke care 
in Sweden exist to some extent. Lower functional status after stroke in women compared to men 
stands out as a general finding [85, 86, 95]. Differences in survival have also been studied in the same 
three articles but with somewhat different conclusions. Eriksson 2009 [85] found that women 
survived the first three months after stroke to a significantly lower degree than men (OR 1.080, 95% 
CI 1.008-1.158). Regression models within this study were adjusted for sex and age. However, 
assessing survival in men and women stratified by level of consciousness at arrival to hospital 
showed that women survived the first three months to a larger extent than men (OR 0.899, 95% CI 
0.831-0.974). No significant difference in three-month survival was found by Nathanson 2014 [86] 
although the authors comment that this may depend on a relatively small study sample. Glader 2003 
[95], with a larger study sample (19,547 stroke patients evenly distributed between sexes) and 
multiple adjustments simultaneously performed, did however also conclude that there were no 
significant differences in case fatality at three months after stroke between men and women. 
Eriksson 2013 [93] found that the risk of death after stroke in diabetes patients was significantly 
higher in women than in men (adjusting for several confounders including patient characteristics, 
functional status, comorbidity, stroke severity, care process measures and socioeconomic factors). 
According to Nathanson [86], women gained relatively more than men with thrombolysis treatment 
– going from a worse state at stroke onset to a similar status after treatment, with a significant 
difference in functional recovery, although the study sample was relatively small (n=355). Glader 
2013 [89] found that women were treated at a specialized stroke unit to a lower degree than men 
(OR 0.97, 95% CI 0.95-0.99), having adjusted for confounders such as age, living situation, ADL 
dependency, comorbidity, education and income. 
Age differences between men and women at stroke onset were presented in four of the five studies 
and highlighted as an important reason for differences in how stroke present in women versus men 
as well as in the treatment process. For example, Eriksson 2009 [85] concluded that men were on 
average 4.8 years younger than women and presented age and more severe strokes (level of 
consciousness at hospital arrival) as the major reasons for women’s lower degree of survival at three 
months after stroke onset. Age differences between men and women at stroke onset amounted to 
4.4-7.0 years in the studies included in the review. 
Prescription, adherence (four months) and persistence (two years) to prescription were studied by 
Sjölander 2012 [88]. The authors found that women were prescribed statins (age-adjusted 
prevalence ratio, PR, 0.86; 95% CI 0.82-0.91) and warfarin (PR 0.88; 95% CI 0.79-0.97) to a lesser 
extent (adjusted for different patient characteristics in separate models as presented in Table 1). 
There was no difference in what the authors call primary non-adherence (filled prescriptions first 
four months), neither regarding persistence (filled prescriptions first two years) except for 
antihypertensive treatment with better compliance in women. The authors state that poor 
persistence in general appears to be a great problem in society and that it should receive more 
attention. Similar results were shown by Geary 2017 [97] who studied a stroke cohort from 
Stockholm county. Female sex, lower educational level and income were associated to lower 
utilization of statins after ischemic stroke. Glader 2003 [95] also concluded that female sex was 
associated with lower degree of oral anticoagulants prescription, after adjusting for patient 
characteristics, functional status prior to stroke and clinical status at stroke onset. 
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Life satisfaction after stroke and potential differences between women and men were studied by 
Röding 2010 [94]. The authors concluded that there are different drivers of life satisfaction in women 
versus in men. Further, the women included in the study were less satisfied with their vocational and 
financial situation than the men. 
Three of the included articles on diabetes studied sex differences [98, 101, 104]. A common finding 
for these were that women were worse off regarding the outcome studied (diabetes-related event 
mortality, HbA1c levels, and progress of ischemic heart disease risk). However one of them, Wiréhn 
2008 [101], found that ischemic heart disease (IHD) afflicted men to a larger extent in each age 
stratum, but the main finding was that progress of IHD risk due to diabetes was significantly more 
severe in women. The extent of case-mix adjustments made within these studies varied; all adjusted 
results for age differences, one also included comorbidity, and in one (Samuelsson 2016 [106]) 
results were also adjusted for diabetes duration, smoking, BMI and physical activity. 
 
2.1.2 Socioeconomics 
Education has been put forward as one of the best variables for assessing socioeconomic association 
with outcomes in a Swedish context and therefore as the most commonly used [39]. It is also 
relatively standardized over time (standardization on micro-data level performed by Statistics 
Sweden [108]). Education could be viewed as a determinant of other socioeconomic measures such 
as income, although this may not always be the case. Income was included as a predictor for 
differences in health, resource use or process in six of the 13 stroke articles and in three of the 10 
diabetes articles. Country of birth and/or immigration and the association of these with outcomes 
was explicitly the objective in three of the diabetes articles. One of these also studied the extent of 
association over generations by comparing outcomes in first-generation immigrants and second-
generation immigrants. 
Most articles included in this review which were not treating sex differences specifically did instead 
treat socioeconomic differences and/or their potential impact on outcomes. For stroke, the studies 
treated access to reperfusion therapy dependent on education level [87], access to stroke unit care 
dependent on education and income [89], prescription of statins and prescriptions of anticoagulants 
to stroke patients with atrial fibrillation dependent on education, income and country of birth [90, 
97], return to work after stroke dependent on education and income [91], and stroke fatality 
dependent on education, income, country of birth and living situation [92]. Also, differences in risk of 
death after stroke dependent on cardiovascular risk factors, socioeconomics (education, income and 
country of birth) and diabetes diagnosis were assessed in one study [93]. 
In general, for the above-mentioned studies, socioeconomic dimensions were in fact found to be 
associated with the outcomes studied. University education and secondary education were 
associated with higher rates of reperfusion therapy (thrombolysis and/or thrombectomy) after 
ischemic stroke compared to primary education, adjusted for a wide range of patient characteristics 
as presented in Table 1 [87]. Also, a socioeconomic gradient regarding access to stroke unit care was 
presented [89]; although diminishing over time, patients with university education or secondary 
education as highest educational level were treated at stroke unit to a higher degree than patients 
with primary education as highest educational level. Income was not significantly associated with 
access to stroke unit care. 
Sjölander 2015 [90] assessed prescriptions of oral anticoagulants (OAC) in first-ever ischemic stroke 
patients with atrial fibrillation and found that OAC prescriptions were less common in patients born 
outside of Sweden, in patients with primary school education compared to university education, in 
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patients with highest income compared to lowest income (analysed in tertiles) and that they were 
less common with higher age. These analyses were also adjusted for patient characteristics such as 
stroke severity (level of consciousness at hospital arrival), ADL dependency, comorbidity and 
smoking. 
Glader 2016 [91] found return to work to be less common in patients with low income compared to 
high income (analyzed in tertiles), after adjustment for other relevant factors such as sex, age and 
functional status. However, when also adjusting for whether the patient answered the questionnaire 
on his/her own or with help, no significant differences were identified on the socioeconomic 
dimensions studied (income, education, country of birth). 
Lindmark 2013 [92] identified a socioeconomic gradient in stroke case fatality, present already within 
8-28 days after stroke onset. Income and cohabitation were factors associated with differences, and 
the association increased with fatality >28 days. Educational level was associated with fatality >28 
days whilst country of birth was not significant for any of the two phases of fatality. Analyses were 
also adjusted for sex, age, comorbidity, smoking, stroke severity (level of consciousness at hospital 
arrival), medication and year of stroke onset. 
Of the diabetes studies evaluating association with socioeconomics, three studies explicitly focused 
on immigration [98, 99] or ethnicity [103], one treating T1D and two treating T2D. One diabetes 
study [100] assessed income specifically – the impact of T1D onset on income. For the remaining 
three articles on socioeconomic association (one regarding T1D, two regarding T2D), several factors 
were assessed simultaneously and none of the ones included (education, income, country of birth, 
marital status) were particularly emphasized according to the study objectives. 
According to the articles assessed within this review, there are significant and unwarranted 
differences between native Swedes and immigrants regarding outcomes in individuals with T1D and 
T2D. Söderström 2016 [98] assessed glycemic control in children with T1D born to immigrants versus 
native Swedes. They found that second-generation immigrants with T1D had significantly higher 
HbA1c after three years of treatment compared to their Swedish peers, whilst the frequency of 
ketoacidosis and hypoglycemia did not differ between the groups. Li 2013 [99] studied the risk of 
hospitalization due to T2D in first-generation and second-generation immigrants. They found that 
differences in the risk of T2D-related hospitalization compared to patients of native Swedish descent 
were weakened in second-generation immigrants compared to first-generation, and the authors put 
forward that environmental factors are likely of greater importance than genetic factors in this 
context. These conclusions stress the significance of personalized, patient-centered lifestyle 
interventions. 
Rawshani 2015 [103] found ethnicity to be a significant predictor of poorer glycemic control in T2D 
patients (after adjustment for relevant confounders such as sex, age, diabetes duration, BMI, 
smoking, previous CVD, physical activity, medication, eGFR, income and education) – in spite of that 
these same groups of immigrants received glucose-lowering therapy earlier than the native Swedish 
peers and had a higher number of medical consultations. 
Steen Carlsson 2010 [100] studied long-term (up to 15 years) consequences of income dependent on 
T1D onset. The authors found no significant difference before onset. After T1D onset, adjusting for 
relevant confounders such as employment, own and parental education, they found that individuals 
with T1D diagnosis earned less (on average 5.3%) and were less likely to be employed. The authors 
stress the importance of personalized medicine and self-management improvements to increase not 
only health in T1D individuals but also productivity on today’s labor market. T1D generally afflicts 
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younger individuals compared to T2D and stroke, and the burden of disease in terms of disability to 
work may be substantial to society. 
The three studies assessing simultaneous association between different socioeconomic factors and 
health outcomes (cardiovascular disease in T1D, mortality in T1D and T2D, and end-stage renal 
disease in T2D) found that several factors do influence health in T1D and T2D patients. Rawshani 
2015 [107] concluded that marital status (never married compared to married), income level (lowest 
two quintiles compared to highest quintile), educational level (primary school compared to university 
degree), country of birth (born in Sweden versus outside Sweden) and sex (men compared to 
women) have significant (negative) impact on the risk of cardiovascular disease and death in 
individuals with T1D. Rawshani 2016 [105] found the exact same socioeconomic factors to have 
significant impact on mortality (all-cause, cardiovascular, cancer) in individuals with T2D. One 
relationship of particular interest is the so called healthy migrant effect, which is a term for a lower 
mortality risk in (non-Western) immigrants compared to native Swedes, suggesting that these 
immigrants “represent a select and stronger subgroup of their native country” [105]. Pazzagli 2017 
[102] concluded that unemployment and receiving income support are associated with higher risk of 
developing end-stage renal disease in individuals with T2D. 
 
2.1.3 Geography 
Only one of the studies included in this literature review treated geographic comparison within 
Sweden; Glader 2004 [96] assessed regional variations in the degree of prescription of oral 
anticoagulants before and after stroke onset in patients with atrial fibrillation. Regional variations 
were significant after adjustment for differences in sex, age, functional status and comorbidity, and 
the authors conclude that region-level factors (and hence not always national evidence-based 
recommendations and guidelines) determine whether stroke patients receive optimal treatment or 
not, regarding primary as well as secondary stroke prevention. 
In addition, Stecksén 2014 [87] assessed whether differences in hospital specialization, which may be 
related to geographical situation, seem to have an impact on the probability of receiving reperfusion 
therapy after ischemic stroke. Differences in treatment dependent on educational level were not 
significant except for in large non-university hospitals, where university education and secondary 
education were associated with higher rates of reperfusion therapy compared to primary education. 
One of the diabetes studies, which were excluded due to studying T2D incidence and not outcomes 
for already diagnosed diabetes patients, treated geographic differences [109]. 
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2.2. Recent development and initiatives in Sweden 
Several Swedish authorities have healthcare analysis as a part of their mission. The National Board of 
Health and Welfare (Socialstyrelsen) states that the authority works for "access to good health and 
social care on equal terms" [110]. An example of this continuous work is the online database on 
selected indicators for several conditions (Vården I Siffror [111]) that are intended to reflect the 
situation in Swedish healthcare across the different regions. The Swedish Agency for Health and Care 
Services Analysis (Myndigheten för vård- och omsorgsanalys) states, in the report "Equal care is 
possible”, that patient characteristics such as sex, ethnicity, sexual orientation and socioeconomic 
conditions should not affect the extent of care and treatment that the patient receives, and neither 
should place of residence or region of care [112]. Initiatives on health equity have been established 
at different levels within Swedish healthcare. One example is the Commission for Equal Health 
(Kommissionen för jämlik hälsa), appointed by the Swedish government in 2015. The Commission's 
main focus was around health differences between socioeconomic groups and disparities between 
sexes [113]. For Swedish stroke and diabetes care specifically, national programs have been 
established with the objective to collect and enhance availability of knowledge on the conditions and 
their treatment. The programs are financed by the Swedish Association of Local Authorities and 
Regions (Sveriges Kommuner och Landsting) [114]. 
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3. Aims and contributions 
3.1 Aims of the thesis 
Equity in health and healthcare has several dimensions. Equity can be analyzed based on access, level 
and content of the care offered as well as based on the level of health, body function and activity 
achieved after treatment, i.e. health outcomes. The collective aim of the studies included within this 
thesis was to evaluate the extent of health equity in Swedish healthcare today with stroke and 
diabetes care delivery as examples, based on data for seven of Sweden's regions (approximately 65% 
of Sweden's population). More specifically, to assess and describe possible differences in health 
outcomes, resource use and care process between subgroups of patients undergoing stroke and 
diabetes care respectively, and to analyze what factors that may impact such differences. 
Subgroups selection has been done to reflect a couple of different perspectives on health equity; the 
demographic, socioeconomic and geographic perspectives. Each study was performed to test the 
hypothesis of whether the groups studied had equal health outcomes, resources and/or processes. In 
a case where such a hypothesis can be rejected, there are health inequities. The purposes for the 
individual research papers (I-V) included in the thesis were: 
I. To explore the relationship between patients' sex and post-stroke health outcomes and 
received care in a Swedish setting.  
II. To estimate the level of health outcomes and resource use at a hospital level during the 
first year after a stroke, and to identify any potential differences between Swedish 
hospitals after adjusting for patient characteristics. 
III. To investigate whether Type 1 Diabetes Mellitus care showed absence of systematic 
disparities and unwarranted differences between groups defined by differences in 
sociodemographic situation in a setting with universal, tax-funded healthcare. 
IV. To investigate the association between sociodemographic factors and diabetes-related 
health outcomes in individuals with Type 2 Diabetes Mellitus in a setting with universal, 
tax-funded healthcare. 
V. To explore potential differences in health, resource use, and treatment process after 
stroke for patients with pre-stroke psychosis or schizophrenia, compared to other stroke 
patients, in a setting with universal, tax-funded healthcare. 
 
3.2 Possible contributions 
Conclusions from each separate study reveal potential differences between the subgroups and 
render knowledge regarding which groups that may require additional efforts (i.e. what factors drive 
differences and whether such differences are unwarranted or not). Conclusions could enhance 
identification and spreading of best practices, which could hopefully provide an opportunity to 
increase equity in Swedish stroke and diabetes care delivery and ensure the best possible health 
outcomes and effective use of society's resources. 
As equity is and has been a prioritized topic in the Swedish context, the public debate on how to 
further increase and sustain health equity in society is a continuous discussion on several levels in the 
community. The studies included in this thesis contribute to the research literature with an update 
on the health equity situation for two example conditions, each with a significant contribution to 
society’s total burden of illness. The thesis is supposed to be a timely update regarding the situation 
in Sweden, to deepen the understanding of how health equity can be viewed and measured, and to 
highlight some possible policy implications with regards to the results presented. 
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Decentralization of the decision making within Swedish healthcare to the 21 regional administrative 
regions also renders a continuous urgency to understand how the situation has evolved nationally 
during the last couple of years. The thesis will also show to what extent available registries can be 
used for evaluating health equity. Given the multiple data sources included in the research databases 
and the ability to adjust results for systematic differences between subgroups, conclusions from the 
studies have a possibility to become important knowledge contributions on health equity for stroke 
and diabetes patients in Sweden today. Consequently, the thesis and its studies should be able to 
further enrich the decision base for e.g. prioritization and resource allocation in healthcare systems 
with universal and tax-subsidized healthcare. 
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4. Participants and methods 
For all research papers included in this thesis, the study material consisted of patient-level data from 
regional and national registries. The Sveus databases, which were built from data collected from 
several sources during the thesis project, were leveraged for the five studies performed. Linking of 
data was performed on patient level to enable analysis on outcome drivers on individual level. As the 
data sources cover most of all available research registries in Sweden on the subject, the coverage in 
terms of indicators could be considered high. Table 3 presents an overview of the five studies. 
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Table 3. Study overview for research papers I-V 
Study I II III IV V 
Study period 2010-2011 2010 2010-2011 2010-2011 2008-2011 
Data sources 
Patient administrative 
systems, the Swedish 
stroke register, LISA, 
RTB, SoL, MiDAS 
Patient administrative 
systems, the Swedish 
stroke register, LISA, 
RTB, SoL, MiDAS 
Patient administrative 
systems, the National 
diabetes register, LISA, 
LMR, MiDAS 
Patient administrative 
systems, the National 
diabetes register, LISA, 
LMR 
Patient administrative 
systems, the Swedish 
stroke register, LISA, 
RTB, SoL, LMR 
Inclusion criteria 
Main diagnosis 
inpatient of 
intracerebral 
hemorrhage (I61*) or 
ischemic stroke (I63*) 
and registration in the 
Swedish stroke register 
Main diagnosis inpatient 
of intracerebral 
hemorrhage (I61*) or 
ischemic stroke (I63*) 
and registration in the 
Swedish stroke register 
Main or secondary 
diagnosis of T1D (E10*) 
in PAS and registration in 
the National Diabetes 
Register and/or use of 
insulin according to the 
Prescribed Drug Registry 
Main or secondary 
diagnosis of T2D (E11*) 
in PAS and/or 
registration in the 
National Diabetes 
Register 
Main diagnosis inpatient 
of ischemic stroke (I63*) 
in PAS and registration 
in the Swedish stroke 
register 
Exclusion criteria 
Patients younger than 
18 years of age 
Patients younger than 18 
years of age 
First diabetes diagnosis 
during last year, patients 
younger than 18 years of 
age 
First diabetes diagnosis 
during last year, patients 
younger than 18 years of 
age 
Patients younger than 
18 years of age 
 
Number of episodes  
27 691      14 125             16 367             416 228            46 350     
Ethical approval 
2013/1541-31/5 and  
2016/785-32 
2013/1541-31/5 2013/1197-31 2013/1197-31 
2013/1541-31/5 and  
2016/785-32 
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Figure 8. Schematic overview of general registry availability for patients across the studies in 
research papers I-V. 
4.1 Process setup – the Sveus research and development project 
The Sveus project was initiated in 2013 by the Swedish Ministry of Health and Social Affairs 
(Socialdepartementet) together with seven Swedish regions (Jämtland Härjedalen, Östergötland, 
Dalarna, Uppsala, Skåne, Stockholm and Västra Götaland). Funding was provided by the collaborating 
parties, and seven conditions with different properties were included (hip/knee osteoarthritis, spine 
surgery, maternity care, bariatric surgery, stroke, diabetes and breast cancer). 
The overarching purpose of the project was to enable healthcare-providing caregiving units and 
healthcare-financing regions to analyze and monitor healthcare in a more sophisticated way than 
previously, to enhance patient-centered and equitable healthcare as well as to enhance a stimulating 
work place environment for healthcare personnel. One main activity to achieve this purpose was to 
develop a set of key performance indicators per condition and to reach consensus within assigned 
expert groups on what indicators to analyze in order to assess patient-centered performance (levels 
of health outcomes, resource use and care process), how to define these indicators and select factors 
of high relevance to adjust for when assessing performance. 
4.1.1 Gathering of expertise 
To enable alignment and receive expert input from the Swedish scientific and clinical community, 
multi-disciplinary expert groups were gathered with representatives from several clinical and 
scientific expert bodies as well as all regions participating in the research project. For each condition 
covered, experts in the field were asked to join. The expert group involved in the Sveus stroke project 
is presented in Table 4 and the Sveus diabetes expert group is presented in Table 5, including 
representative affiliations. 
 
 
Patients identified in quality registry
Patients identified in regional patient 
administrative systems
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Table 4. Sveus stroke expert group. Participants and co-authors of the final project report. 
Name Affiliation/Representation 
Sven Andreasson The Swedish Stroke Association (patient representative) 
Elisabeth Ekstrand Swedish Association of Physiotherapists 
Lena Eriksson Region Skåne 
Mia von Euler Karolinska Institutet 
Birgitta Fagervall-Yttling Swedish Association of Occupational Therapists 
Lena Henricson Swedish Association of Speech Therapists 
Konstantin Kostulas SLL/ The Swedish Neurological Society 
Ingrid Lekander Employed at Ivbar, affiliated to Karolinska Institutet 
Mikael Lilja Region Jämtland Härjedalen 
Stefan Olsson-Hau Region Skåne 
Hélène Pessah-Rasmussen Skåne University hospital 
Katharina Stibrant Sunnerhagen Swedish Association for Rehabilitation Medicine/WebRehab 
Jörg Teichert Dalarna county council 
Patrick Vigren Region Östergötland 
Christina Wikman-Lundbom Region Västra Götaland/Swedish Geriatric Society 
Carl Willers Employed at Ivbar, affiliated to Karolinska Institutet 
 
Table 5. Sveus diabetes expert group. Participants and co-authors of the final project report. 
Name Affiliation/Representation 
Gudrun Andersson Swedish Association for Nurses in Diabetes Care 
Ingalena Andersson Swedish Association of Clinical Dietitians, Diabetes section 
Mette Axelsen Swedish Association of Clinical Dietitians, Diabetes section 
Tobias Dahlström Dalarna county council 
Mats Ek Stockholm county council 
Bettina Julin Employed at Ivbar, affiliated to Karolinska Institutet 
Robert Kristiansson Region Uppsala 
Janeth Leksell Swedish Association for Nurses in Diabetes Care 
Mikael Lilja Region Jämtland Härjedalen 
Agneta Lindberg Region Skåne 
Peter Lindgren Employed at Ivbar, affiliated to Karolinska Institutet 
Karin Looström Muth Region Västra Götaland 
Fredrik Löndahl Swedish Diabetes Society (patient representative) 
Ann-Marie Svensson National Diabetes Register 
 
4.1.2 Joint development of definitions and methodology 
The definitions and methodology regarding identification of the study populations, appropriate study 
outcomes, relevant comorbidity and other factors for case-mix adjustments of results were 
developed in consensus with the expert groups within Sveus stroke and Sveus diabetes. Parts of the 
work performed by the expert groups have been published in reports [43, 115]. Sources and 
definitions regarding outcomes and case-mix factors can be found in Table 6 and Table 7. 
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4.2 Data sources 
The study populations for the five studies included in this thesis are based on two original cohorts, 
from one stroke dataset and one diabetes dataset which have been entirely separated throughout 
the project. The data sources leveraged for the two datasets are presented below. 
4.2.1 Regional administrative systems  
All Swedish regions and county councils have patient administrative systems (PAS) which contain 
data related to care contacts registered within their geographical area. These data include care 
contact date, diagnosis and procedure codes (ICD-10, KVÅ) and meta data regarding the caregiving 
unit. The systems generally have very high coverage, and they also include information on care 
contacts within primary care. The density of diagnosis and procedure codes varies across regions. 
For the stroke population, data were retrieved from the seven regions on all adult patients (aged >18 
years) who were registered with an acute stroke diagnosis, ICD-10 code I61* (ICH), I63* (IS) and/or 
I64* (unspecified) as main diagnosis anytime from 2006 to 2012. Information on all care contacts 
registered for these individuals were extracted for the same time period. Data for patients with only 
unspecified stroke (ICD-10 code I64*) registered were extracted but excluded (approximately 2% of 
the total sample) due to the obvious uncertainty related to the specificity in the stroke diagnosis 
which may significantly impact the relevance of being part of the study population. 
For the diabetes population, data were retrieved from the seven regions on all adult patients (aged 
>18 years) who were registered with a diabetes diagnosis (ICD-10 codes E10*, E11* and E14*) 
sometime during 2007-2012. Information on all care contacts registered for these individuals were 
extracted for the same time period. Unspecified diabetes (ICD-10 code E14*) was excluded due to 
the obvious uncertainty related to the specificity in the diagnosis which may significantly impact the 
relevance of being part of the study population. 
These patient-level data were linked to patient-level information from other registries as described 
below. Regional administrative systems data were used for all research papers. 
4.2.2 The Swedish Stroke Register (Riksstroke) 
The Swedish Stroke Register is one of the national quality registries and the single one relating to the 
entire chain of stroke care. Patients with acute stroke (intracerebral hemorrhage or ischemic stroke) 
are included and, during the last years, also patients who have had a transitory ischemic attack (TIA). 
Patients with subarachnoid hemorrhage (SAH) were not included at the time of the studies [116]. 
The register includes information on acute treatment, admission to hospital, secondary prevention, 
patient reported outcomes and experience measures. Data are collected at admission for acute 
stroke care, at three months and at twelve months after the stroke event. Hospitals admitting 
patients with acute stroke are expected to collect and report data, and the coverage rate has been 
estimated to be as high as 97% based on validation with the National Patient Register 
(Patientregistret) [41]. The equivalent coverage rate for the follow-up forms at three months were 
estimated to be 86% [41]. The three-months form can be filled out by the caregiving unit or by the 
patient him-/herself whilst the twelve-months form is sent out to patients via physical mail [7]. 
Data from the Swedish Stroke Register were used in research papers I, II and V; to select the relevant 
study population (confirming stroke cases) as well as for information on patient characteristics and 
health outcomes. Patient-level data were retrieved for all patients with an acute stroke (IS or ICH) 
registered during 2006-2012 in any of the seven regions collaborating within the Sveus research 
project (Jämtland Härjedalen, Östergötland, Dalarna, Uppsala, Skåne, Stockholm, and Västra 
Götaland). 
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4.2.3 National Diabetes Register (NDR) 
The National Diabetes Register is the national quality register for adult diabetes care. It gathers 
information on patient characteristics and risk factors, care process and interventions, laboratory 
results and health outcomes. The coverage rate has been estimated to be 96.5% for all individuals 
diagnosed with diabetes [7]. 
Data from the NDR were used in research papers III and IV; to select the relevant study population 
(confirming cases) as well as for information on patient characteristics and health outcomes. Patient-
level data were retrieved for all patients with a diabetes diagnosis registered during 2007-2012 in any 
of the seven regions collaborating within the Sveus research project (Jämtland Härjedalen, 
Östergötland, Dalarna, Uppsala, Skåne, Stockholm, and Västra Götaland). 
4.2.4 Longitudinal integration database for health insurance and labour market studies (LISA) 
The LISA database, held by Statistics Sweden, covers individual-level information for a broad range of 
socioeconomic parameters. It includes data on all individuals from the age of 16 years and integrates 
information from the educational sector and the labour market on an annual basis. Data from LISA 
were used in all five research papers included in the thesis, and enabled stratification and case-mix 
adjustments with regards to socioeconomic variables. 
4.2.5 Total population register (RTB) 
Statistics Sweden keeps and updates information on individuals’ date of death which is part of the 
Total population register (Registret över totalbefolkningen). This information was used in research 
papers I, II and V. 
4.2.6 Care and social services for the elderly and for persons with impairments (SoL) 
The register is administered by the National Board of Health and Welfare (Socialstyrelsen). It contains 
individual-level information on municipal services provided for elderly and individuals with functional 
variations. Data on housing via the local municipality as well as home-help services were used in 
research papers I, II and V. 
4.2.7 Prescribed drugs registry (LMR) 
All prescriptions that are filled in an outpatient setting are included in a research database held by 
the National Board of Health and Welfare. The database contains information on ATC code level, 
date for filling the prescription, and the attributable amount. 
This data source was leveraged in research paper V (filled prescriptions of antihypertensive and 
anticoagulant medication) as well as in research papers III (confirming Type 1 Diabetes cases) and IV 
(filled statin prescriptions). 
4.2.8 MiDAS database 
Individual-level information on leave due to illness or disability, short-term and long-term with a 
minimum level of two weeks’ absence, is collected in the Swedish Social Insurance Agency’s MiDAS 
database. 
Data from MiDAS were used in research papers I, II and III, to estimate the proportion of stroke 
patients having formally regained full-time work ability and to estimate the proportion of individuals 
with Type 1 Diabetes with formal sick leave or disability pension during two years prior to the study 
baseline. 
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4. 3 Data management, process mapping and study outcomes 
4.3.1 Data management process 
A significant share of the time spent on performing the studies included in this thesis consisted of 
management of data. As described above, data were extracted from 14 different sources, and two 
separate research databases were built on 11 (diabetes) or 13 (stroke) of these data extracts. Formal 
data controller of the databases included was Ivbar. Below, a short description of each step within 
the data management process is presented. 
Ordering of data from the data owners. After having received ethical approval, data specifications 
were compiled based on the registries’ existing variable lists and sent to each registry. Data were 
pseudonymized (de-identified but kept on individual level) by Statistics Sweden to minimize the risk 
that individual patients would be possible to identify in the research database (information flow 
process presented in Figure 9). 
Validation of received data. To secure that all data included in the data extracts received were 
stored in a structured, readable format and to secure that all data extracts were complete, all data 
extracts were explored, and counts and values of the data for the different variables were assessed. 
If needed, which was the case at a few occasions, the registry was contacted to validate the shared 
data extract, to double-check its contents, and possibly to re-send it. In at least one case, a new data 
extract was created and shared by the registry in order to complete the dataset according to the 
original data order. 
Harmonization of definitions across registries. The different data sources have their own variable 
lists with different scope and somewhat different denominations. For example, different ways of 
assigning a care contact to specialized outpatient care versus primary care needed harmonization 
across regional administrative data. Some activities are possible to register in the health record as 
well as in the quality registry, and the selection of which variable to use was done on a case-by-case 
basis (e.g. assessing thrombectomy via the Swedish Stroke Register instead of using the patient 
administrative data), dependent on the variable’s coverage rate. 
Identification of study populations. Based on joint discussions in the expert groups, definitions of 
the study populations within data extracts from the regional administrative systems were set based 
on diagnosis (ICD-10) codes. These definitions were re-used in all research papers included in the 
thesis. Based on the definitions of eligibility within other registries, data from these registries were 
linked on patient level. 
Definition of outcomes. The study outcomes were defined together with the expert groups. The 
definitions were based on existing guidelines and the clinical experience of the expert group 
members. Definitions were designed to include any variants in coding routines within the different 
regions. These definitions were re-used in all research papers included in the thesis. 
Definition of patient characteristics. After having selected which patient characteristics to include in 
the datasets, these were defined and reviewed in open discussions within the expert groups. 
Definitions were designed to include any variants in coding routines within the different regions. 
These definitions were re-used in all research papers included in the thesis. 
Validation of the study population, its characteristics and outcomes. The patient volumes of the 
study populations, and its levels of indicators concerning both patient characteristics and outcomes 
were validated via cross-checking with previous research and public reports during open discussions 
within the expert groups. 
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Figure 9. Process for enabling pseudonymized global patient-level ID with support from 
Statistics Sweden. Adopted from reports published under the Sveus research and development 
project [43, 115] 
 
4.3.2 Care process mapping 
In order to decide on relevant indicators for measurement and analysis, mapping of the care 
processes was performed. Input from representatives for the seven Swedish regions (Table 4 and 
Table 5) was leveraged to include the different existing variants. 
 
4.3.2.1 Stroke 
Securing high-quality care for the individual stroke patient is dependent on a broad range of 
competencies within the healthcare sector and possibly over a long period of time. Activities need to 
be coordinated across departments at the caregiving unit, and sometimes at several caregiving units.  
Study populations for the studies included in this thesis are defined based upon the stroke diagnosis 
and, hence, the mapped care process includes activities after stroke onset. When mapping the care 
process, it was divided into three phases over time, starting at stroke onset; the first phase includes 
pre-hospital activities and measures taken to limit the damage of the stroke, the second phase 
includes acute interventions, and the third phase includes post-acute and long-term activities such as 
rehabilitation. 
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Figure 10. First phase of the stroke care process. Adopted from report published under the Sveus 
research and development project [43]. 
The first phase, the pre-hospital phase, is defined by the time from the stroke event to hospital 
arrival, including patient delay in contact with healthcare, triage and initial assessment of the patient. 
The shorter the amount of time spent in the first phase, the better, as time of brain tissue ischemia is 
a strong predictor for outcomes after stroke [117]. The eligibility of some potentially crucial 
treatment interventions is also dependent on the time window from stroke (symptom) onset to start 
of intervention. 
Pre-hospital conditions for the individual stroke patient are potentially important factors in terms of 
treatment initiation: living conditions such as living at home or at a facility (e.g. sheltered or special 
housing) as well as living alone impact the ability to alert the changed state of health and body 
function; level of understanding of the symptoms and implied sense of urgency impact approach for 
seeking care (what care level) and with what urgency; living in a rural area impacts options regarding 
available transporting arrangements, to mention a few. 
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Figure 11. Second phase of the stroke care process. Adopted from report published under the Sveus 
research and development project [43]. 
The second phase, or the acute phase, includes detailed examination, preparation for intervention, 
intervention as well as monitoring before, during and after the intervention. Generally, the stroke 
patient undergoes radiological examination, usually computed tomography (CT), to determine 
whether the stroke is ischemic or hemorrhagic. A CT-angiography determines whether there is a 
large-vessel occlusion, and thus an indication for thrombectomy. Furthermore, hemorrhagic stroke 
aneurysms and other vessel malformations are visualized. 
If the stroke is confirmed as ischemic, dependent on the amount of time spent in the pre-hospital 
phase and given no contraindications, the patient may be eligible for thrombolysis and/or 
thrombectomy. Also, hemicraniectomy may be applicable for patients with a very large ischemic 
stroke in the media artery of the frontal brain lobe. Patients with hemorrhagic stroke may in selected 
cases undergo treatment with evacuation of hematoma. 
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Figure 12. Third phase of the stroke care process. Adopted from report published under the Sveus 
research and development project [43]. 
The third phase, including post-acute and long-term activities, is of varying length but in many cases 
life-long. Main activities include rehabilitation – to enable rebuilding of functions to pre-stroke levels 
or adaptation to a new situation with lower level of body function – and secondary prevention, to 
reduce the risk of stroke recurrence. 
The amount of resources put into rehabilitation and secondary prevention may have significant 
impact on long-term outcomes. Several different healthcare professionals are involved during 
rehabilitation, e.g. physiotherapists, occupational therapists, speech therapists, and psychologists. 
The probability of receiving inpatient rehabilitation offered before discharge versus less intense 
rehabilitation activities outpatient or at special housing may play an important role in how well the 
patient regains health. 
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4.3.2.2 Diabetes 
The individual’s path to diagnosis with diabetes can look very different. There is a significant 
difference between the patient journey leading up to T1D and that leading up to a T2D diagnosis. 
These two groups of patients are also generally different in terms of age as well as health profile at 
diagnosis. Diabetes care is managed at primary care facilities (primarily Type 2 Diabetes) or at 
hospitals. The care process concisely described below varies somewhat depending on regional and 
local routines. 
Guidelines published by the National Board of Health and Welfare state that it is desirable to 
maintain HbA1c levels beneath 52 mmol/mol, although the risk-benefit ratio for a treatment 
intensity needed to reach that level is individual and ought to be assessed on a case-by-case basis. 
HbA1c levels should however not exceed 70 mmol/mol as the risk of diabetes-related complications 
increases significantly above this level [83]. 
 
 
Figure 13. Overview of the care process for an individual with Type 1 Diabetes. Adopted from 
report published under the Sveus research and development project [115]. 
Individuals with Type 1 Diabetes are generally treated inpatient during the first few days after 
diagnosis (length of stay may vary dependent on initial health state and regional/local routines). As 
these individuals are dependent on insulin injections, it is of great importance for the individual to – 
in addition to initiate a good balance of the hormone as soon as possible – learn how to manage 
these injections and how to perform self-testing to enable adequate dosage. After the initial 
inpatient stay, follow-up is performed within specialized outpatient care. The standard process 
includes appointment with dietitian and fundus photography which is also performed with regular 
intervals over time. 
The first year after diagnosis is usually more intense in terms of follow-up visits for patient education 
and maintaining a good level of self-care than subsequent years. Follow-up visits include injection 
techniques, selection of insulin and laboratory tests. 
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Figure 14. Overview of the care process for an individual with Type 2 Diabetes. Adopted from 
report published under the Sveus research and development project [115]. 
Healthcare for individuals diagnosed with Type 2 Diabetes is typically managed in primary care. After 
initial diagnosis and initiation of pharmacological treatment (possibly including insulin injections), 
patient education can be managed individually or in a larger group. Early appointment with foot 
therapist and performance of fundoscopy are desirable. Follow-up is somewhat more intense during 
the first year after diagnosis than subsequent years with diabetes nurse visit after six months, 
laboratory tests and a doctor’s visit after one year. From that point on it is desirable to have at least 
one follow-up per year including laboratory tests, to ensure appropriate treatment. 
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4.3.3 Study outcomes, sources and definitions  
Assessment of health equity was carried out based on a broad set of outcomes, to reflect the main 
elements and results from the care processes illustrated in Figure 10-Figure 14. 
Table 6. Study outcomes, sources and definitions. Overview of the study outcomes for research 
papers I-V, their sources and definitions. 
Study outcome Research 
paper I 
Research 
paper II 
Researc
h paper 
III 
Research 
paper IV 
Research paper V 
Health 
outcomes 
     
Survival Date of death 
(SCB) vs. date 
of stroke (PAS) 
Date of death 
(SCB) vs. date 
of stroke (PAS) 
- - Date of death 
(SCB) vs. date of 
stroke (PAS) 
Disease 
recurrence 
Date of new 
main diagnosis 
>28 days after 
index event 
(PAS) 
Date of new 
main diagnosis 
>28 days after 
index event 
(PAS) 
- - Date of new main 
diagnosis >28 
days after index 
event (PAS) 
Functional 
status 
Approximated 
based on 
Eriksson et al 
[118], at 
twelve months 
after stroke 
Approximated 
based on 
Eriksson et al 
[118], at 
twelve months 
after stroke 
- - Approximated 
based on Eriksson 
et al [118], at 
three months and 
twelve months 
after stroke 
General health Patient-
reported on 
an ordinal 
scale one year 
after stroke 
(Riksstroke) 
Patient-
reported on 
an ordinal 
scale one year 
after stroke 
(Riksstroke) 
- - - 
Formal 
complete work 
ability 
Not registered 
for sick leave 
part-/full-time 
or disability 
pension (SoS) 
Not registered 
for sick leave 
part-/full-time 
or disability 
pension (SoS) 
- - - 
HbA1c level - - Absolute 
level 
(NDR) 
Absolute 
level (NDR) 
- 
eGFR - - One-year 
change 
(NDR) 
- - 
Predicted 5-
year risk of CVD 
- - One-year 
change 
(NDR) 
Absolute 
level (NDR) 
- 
Systolic blood 
pressure 
- - - Absolute 
level (NDR) 
- 
LDL cholesterol 
 
 
 
- - - Absolute 
level (NDR) 
- 
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Resource use      
Inpatient care Initial 
inpatient stay 
(PAS), total 
first-year 
inpatient stay 
(PAS) 
Initial 
inpatient stay 
(PAS), total 
first-year 
inpatient stay 
(PAS) 
- - Initial inpatient 
stay (PAS), total 
first-year 
inpatient stay 
including/ 
excluding at 
psychiatric unit 
(PAS) 
Outpatient care First-year 
(PAS) 
Specialty care 
first-year 
(PAS), primary 
care first-year 
(PAS) 
- - First-year (PAS) 
Home-help 
services 
Added hours, 
i.e. first year 
vs. prior to 
stroke (SoS) 
Added hours, 
i.e. first year 
vs. prior to 
stroke (SoS) 
- - Added hours, i.e. 
first year vs. prior 
to stroke (SoS) 
Care process      
Special housing Transfer to 
(SoS) 
Transfer to 
(SoS) 
- - - 
Sick leave Net days (FK) - - - - 
Thrombolysis Yes/No 
(Riksstroke) 
- - - Yes/No 
(Riksstroke) 
Thrombectomy Yes/No 
(Riksstroke) 
- - - Yes/No 
(Riksstroke) 
Endarter-
ectomy 
- - - - Yes/No within 14 
days after index 
event (PAS) 
Patient 
satisfaction 
Patient-
reported on 
an ordinal 
scale three 
months after 
stroke 
(Riksstroke) 
- - - - 
Antihyper-
tensive 
medication 
- - - - Filled prescription 
after one-year 
follow-up (SoS) 
Oral 
anticoagulant 
- - - - Filled prescription 
after one-year 
follow-up (SoS) 
Statin use - - - Filled 
prescription 
after one-
year follow-
up (SoS) 
- 
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4.4 Statistical methods and case-mix factors 
Throughout the five studies, analysis has included descriptive statistics of the study sample’s baseline 
characteristics and the study outcomes, as well as results of the study outcomes adjusted based on 
these baseline characteristics. Multivariate regression analysis was performed using selected 
relevant confounders as independent explanatory variables. Continuous data (e.g. absolute HbA1c 
levels, number of home-help services hours) were analyzed using ordinary least squares (OLS) 
regression, count data (e.g. care days, outpatient visits) were analyzed using negative binomial 
regression, and binary data (e.g. survival, presence of a specified comorbidity) were analyzed using 
logistic regression. Regression coefficients were presented in the main document or in supplemental 
material of each research paper except for research paper II. For the results to be considered 
statistically significant, two-sided P values less than 0.05 were needed. The software STATA 13.0 was 
used for statistical analyses. 
In order to separate the correct effect attributable to demographic, socioeconomic or geographic 
factors, it is of importance to adjust for other relevant factors. These factors are different depending 
on the condition studied (e.g. disease-specific factors for stroke or diabetes) and can in theory differ 
systematically between the sociodemographic and geographic groups. The set of case-mix factors 
used in multivariate regression analysis within each research paper is presented in Table 7 and was 
subject to discussions together with clinical expertise. The demographic characteristics included sex 
(woman/man) and age in years from administrative data. Highest educational level (from LISA, SCB) 
was stratified in three levels as according to common practice [108], and origin (LISA, SCB) was 
stratified in four categories; born in a Nordic country, born in the EU, born in non-EU Europe and 
born outside Europe. Marital status (LISA, SCB) was used in four categories (never married, married, 
divorced, widowed). Highest educational level was selected as case-mix factor instead of income 
level, as previous research points to education as being of higher explanatory value [119]. Patient 
characteristics with low coverage were excluded as explanatory variables in order not to lose a 
significant share of the study material (e.g. NIHSS which had a coverage rate of less than 50% for the 
stroke populations). 
Diagnosis (ICD-10) and procedure (KVÅ) codes from the regional patient administrative systems were 
used to collect patient-level information on medical history during two years prior to baseline. 
Prescription (ATC) codes were used for collecting information on filled prescriptions from the 
Prescribed Drugs Registry, previously shown to be appropriate for studying drug utilization patterns 
[120]. Data from the Swedish Stroke Register were used for identification of several study variables; 
all patient-reported outcomes and physician-reported prescriptions at discharge, identification of 
reperfusion treatment, as well as to approximate functional status (the modified Rankin Scale, mRS) 
at three months and one year after the stroke event based on a previously developed algorithm 
[118]. Data from the National Diabetes Register were used for study outcomes, information on 
diabetes duration, BMI and smoking status. In addition, NDR data were used for computation of 
eGFR and five-year risk of CVD [121, 122]. Additional information regarding data sources used can be 
found under section 4.2 Data sources. 
Output from the regression analyses has been used to make predictions based on pre-specified 
patient characteristics, e.g. for the different healthcare providers performance assessed in research 
paper II (in part presented in reports [43, 115]). These predictions are not presented within this 
thesis. 
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Table 7. Case-mix factors applied, per research paper. 
Research 
paper 
Demographic Socioeconomic Geographic Disease-specific factors 
including comorbidity 
I 
 
Sex, age 
(categorical) 
Educational level, 
region of birth, marital 
status, single 
household, living 
arrangements 
- Level of consciousness at 
hospital arrival, ADL 
dependency, prior stroke, 
inpatient care year (-1), 
atrial fibrillation, 
hypertension (stroke 
subtypes analyzed 
separately) 
II 
 
Sex, age 
(categorical) 
Educational level, 
region of birth, marital 
status, single 
household, living 
arrangements 
Hospital Level of consciousness at 
hospital arrival, ADL 
dependency, prior stroke, 
inpatient care year (-1), 
atrial fibrillation, 
hypertension, stroke 
subtype 
III 
 
Sex, age 
(categorical) 
Educational level, 
region of birth, marital 
status, disability 
pension/sick leave 
- BMI, diabetes duration, 
smoking, disease history, 
prescribed insulin pump 
IV 
 
Sex, age 
(categorical) 
Educational level, 
region of birth, marital 
status 
- BMI, diabetes duration, 
smoking, disease history, 
HbA1c at baseline, eGFR 
at baseline, systolic blood 
pressure at baseline, LDL 
level at baseline 
V 
 
Sex, age 
(categorical) 
Educational level, 
region of birth, marital 
status, single 
household, living 
arrangements 
- Level of consciousness at 
hospital arrival, ADL 
dependency, prior stroke, 
inpatient care year (-1), 
atrial fibrillation, 
hypertension, stroke 
subtype, and pre-stroke 
psychosis/schizophrenia 
diagnosis 
 
4.4.1 Research paper I 
The study population was divided in two, to analyze the two stroke subtypes (IS and ICH) separately. 
In addition to assessing crude values of study outcomes between sexes, sex was used as case-mix 
factor in univariate regression analysis of all outcomes. 
Multivariate regression analysis was performed with the independent variables (case-mix factors) 
presented in the above table. Analysis of study outcomes other than survival was based on patients 
that had survived at the time points studied (e.g. patient-reported outcomes at three and 12 
months). Hypertension and atrial fibrillation were included for the analysis of stroke recurrence. 
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4.4.2 Research paper II 
The multivariate model was adjusted for clustering of patients within clinics in addition to case-mix 
factors presented in the above table, and the case-mix adjusted results were presented per 
caregiving unit to illustrate the hospital effect on each dependent outcome. Stroke subtype was used 
as case-mix factor to take the different pathways of IS versus ICH care into account. Hypertension 
and atrial fibrillation were included for the analysis of stroke recurrence. 
Caregiving units were classified as significantly better or significantly worse, as shown in Figure 16 
and Figure 17, based on significant deviations in one direction (formal full-time work ability was not 
included under these criteria as it is not to be considered the equivalence to actual work ability). 
Analysis of study outcomes other than survival was based on patients that had survived at the time 
points studied (e.g. patient-reported outcomes at three and 12 months). 
 
4.4.3 Research paper III 
The multivariate model was adjusted for clustering of health outcomes within individual patients, as 
some patients contributed to the study material with more than one one-year episode. The result of 
this was somewhat more robust standard deviations and confidence intervals of the case-mix factors’ 
effect on outcome. The association between age groups and outcome was also modelled using 
restricted cubic splines in accordance with previous research [107, 123] but did not show higher 
degree of determination. Previous sick-leave or disability pension was added as case-mix factor for all 
three study outcomes. 
Levels of eGFR were estimated with the revised Malmö-Lund formula [121] on patient level. Annual 
development of eGFR was computed through subtracting eGFR at the end of the year with eGFR at 
baseline. To compute the five-year risk for CVD on patient level, an algorithm developed on NDR real-
life data was used. It is based on eight input variables including age, duration of diabetes, ratio of 
total cholesterol versus HDL–cholesterol, HbA1c level, systolic blood pressure, smoking status, macro 
albuminuria status and history of heart conditions [122]. Risk predictions were computed for patients 
with all input values registered within ±3 months from baseline and end of follow-up. 
 
4.4.4 Research paper IV 
The multivariate model was adjusted for clustering of health outcomes within individual patients, as 
some patients contributed to the study material with more than one one-year episode. The result of 
this was somewhat more robust standard deviations and confidence intervals of the case-mix factors’ 
effect on outcome. Multiplicative interactions were also tested using the likelihood ratio test. 
To compute the five-year risk for CVD on patient level, the algorithm developed on NDR real-life data 
was used including eight input variables; age, duration of diabetes, ratio of total cholesterol versus 
HDL–cholesterol, HbA1c level, systolic blood pressure, smoking status, macro albuminuria status and 
history of heart conditions [122]. Risk predictions were computed for patients with all input values 
registered within ±3 months from baseline. Levels of eGFR were estimated with the revised Malmö-
Lund formula [121] on patient level. 
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4.4.5 Research paper V 
The subpopulation of stroke patients with history of pre-stroke psychosis or schizophrenia was 
identified by having had at least one care contact with main or secondary diagnosis of ICD-10 codes 
F20-F29. The diagnosis had to be registered during the two years preceding the stroke event, in 
either inpatient or outpatient care. Only patients with ischemic stroke were included. 
Analysis of study outcomes other than survival was based on patients that had survived at the time 
points studied (e.g. patient-reported outcomes at three and 12 months). For the analysis of stroke 
recurrence, hypertension and atrial fibrillation were included as case-mix factors, and the analysis of 
filled prescriptions of oral anticoagulants was performed for patients with a history of atrial 
fibrillation only. 
 
4.5 Ethical considerations 
The studies included in this thesis have been approved by the Regional Ethical Review Board in 
Stockholm (reference numbers 2013/1541-31/5 and 2016/785-32 for the studies on stroke, 
reference number 2013/1197-31 for the studies on diabetes). All studies are based on registry data. 
As registry data include sensitive data for the individuals included, it is of high importance to secure 
that only data needed are included in the data export from the registries, and to make sure that the 
data are kept in a secure setting. 
The studies were initiated after formal application approved by the Regional Ethical Review Board in 
Stockholm. Subsequently, each data holder approved use of data for the study. In the studies 
performed, only pseudonymized data were accessible and the data were kept in a secure setting on a 
separate server with individual two-factor authentication login. In scientific communication, only 
aggregated data which are impossible to triangulate or link to any individual have been presented. 
Potential harm on patients’ lives by including them in the studies was deemed to be minor whilst 
increased knowledge based on the results may serve as a base for better understanding of health 
equity today. 
As for registry studies performed in Sweden, no formal informed consent from the patient is needed 
for approval by the ethical boards. Regional administrative systems are examples of data sources 
used in these studies that register patient information for all patients, whilst data from quality 
registries such as the Swedish Stroke Register and the National Diabetes Register are possible for the 
patient to choose not to be part of. The decision mandate for the individual patient is limited 
regarding information linked to their identity (although it remains pseudonymized), but it enables 
research and enhances thorough understanding of diseases and their treatments, benefiting patients 
and society in general. 
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5. Results and learnings from research papers I-V 
Below is a summary of results from each of the five research papers included in the thesis. 
 
5.1 Your sex is associated with your results after stroke – results from research paper I 
We analyzed post-stroke levels of health outcomes and healthcare received in relation to sex, for 
ischemic stroke and intracerebral hemorrhage. 
The study population consisted of 27,691 patients whereof 49.7% women and 50.3% men. 88.2% had 
suffered an ischemic stroke and 11.8% had an intracerebral hemorrhage. Within a year, 23.4% were 
deceased (26.8% of women and 19.9% of men) in the ischemic stroke subpopulation, and 40.3% 
(42.0% of women and 38.9% of men) in the hemorrhagic subpopulation. Women were to a larger 
extent living in special housing at stroke onset compared to men, and women were in general ADL 
dependent to a larger degree than men. A larger proportion of women than men were unconscious 
at hospital arrival. 
Women were found to have significantly higher one-year survival in multivariate analyses, correcting 
for factors such as stroke severity, risk factors and age at stroke (men showed higher one-year 
survival in univariate analyses). The rate of good one-year functioning (approximated mRS<2) after IS 
was lower among the women. Women had significantly shorter initial inpatient stay (IS and ICH) and 
shorter total first-year inpatient stay (IS), potentially due to that more women were living in special 
housing before and after stroke. High educational level was a significant positive predictor for 
survival first year after stroke and functional status first year after ischemic stroke (data not 
presented in the research paper). 
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Figure 15. Overview of study outcomes. Crude, univariate and multivariate analysis. From research 
paper I [124] with permission from the publisher. 
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5.2 Where you receive treatment is associated with what stroke care you get – results from 
research paper II 
We investigated whether there was a geographical gradient in Swedish stroke care, based on data 
from 35 acute hospitals performing stroke care, within seven different regions covering 
approximately 65% of the Swedish population. 
There were significant variations in patient mix between the caregiving units studied; the proportion 
of patients with ADL dependency prior to stroke varied between 6% and 20%, the proportion living in 
special housing prior to stroke spanned from 2% to 22%. Socioeconomic and demographic 
characteristics varied as well; the proportion of patients with university education spanned from 8% 
to 27%, and mean age at stroke onset varied between 70 and 80 years. 
Six caregiving units seemed to perform significantly better in terms of health outcomes (light grey, 
Figure 16), and seven units performed significantly worse (dark grey, Figure 16) after adjustments. 
Caregiving units generally seemed to leverage one type of resource in the post-acute phase, e.g. 
inpatient care versus outpatient care or special housing, with higher levels of one type and lower 
levels of the other. Five caregiving units showed significantly lower levels of resources overall (light 
grey, Figure 17) and three caregiving units showed higher levels (dark grey, Figure 17). Adjusted 
deviations from the mean differed between caregiving units; -8 to +16 days in initial inpatient stay, -7 
to +7 visits in specialized outpatient care first year after stroke, and -10 to +21 visits in primary care 
first year after stroke. Trends were identified within regions regarding the relationship between 
outpatient visits in specialized versus primary care; e.g. lower number of primary care visits and 
higher levels of specialized care (Region Skåne) and vice versa (Region Västra Götaland). 
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Figure 16. Health outcomes after stroke for 35 Swedish caregiving units. Adjusted differences 
between caregiving units. From research paper II [125] with permission from the publisher. 
 
Figure 17. Resource use after stroke for 35 Swedish caregiving units. Adjusted differences between 
caregiving units. From research paper II [125] with permission from the publisher. 
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5.3 Your demographic and socioeconomic profile tells us how well you do with Type 1 Diabetes 
– results from research paper III 
We assessed which sociodemographic factors that potentially drive differences in health outcomes 
among Swedish T1D patients, regarding levels of HbA1c, and annual change in eGFR and CVD risk. 
Absolute HbA1c level 
Average HbA1c level in the study population amounted to 64.5 mmol/mol. Several demographic and 
socioeconomic factors were associated with maintaining blood glucose control, after adjustments of 
other relevant patient characteristics and clinical factors. Women showed higher (worse) levels than 
men. Younger patients (below 25 years of age) had higher (worse) levels, and patients in the ages of 
70-74 years had best blood glucose control. 
Patients with university education showed lower levels of HbA1c than patients with high school or 
comprehensive school education, and patients with high school education had lower levels than 
patients with comprehensive school as highest educational level. Married patients showed lower 
levels of HbA1c than never married, divorced and widowed patients. Origin (born in a Nordic country, 
outside the Nordics but within the EU, non-EU Europe or outside of Europe) was not associated with 
absolute HbA1c levels. History of sick-leave and/or disability pension was associated with worse 
blood glucose control, as was smoking. 
In addition, several clinical factors were associated with HbA1c levels; e.g. duration of diabetes, BMI 
and history of diabetes-related complications were associated with worse blood glucose control, as 
was prescription of insulin pump. Renal failure was associated with lower HbA1c levels. 
 
 
 
Figure 18. Absolute HbA1c levels in individuals with T1D. From research paper III [126] with 
permission from the publisher. 
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Annual change in eGFR 
Average level of eGFR amounted to 82.8 ml/min per 1·73 m2, and the average annual development 
in eGFR amounted to -0.43 ml/min per 1·73 m2 per year. Marital status was associated with annual 
development in eGFR; being married was associated with better development than never married. 
There was no statistically significant association between highest educational level and annual 
change in eGFR, nor between region of birth and annual change in eGFR. 
 
Figure 19. Annual change in eGFR in individuals with T1D. From research paper III [126] with 
permission from the publisher. 
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Annual change in five-year CVD risk 
Average five-year risk of cardiovascular disease amounted to 8.5% in the study population, and the 
average annual change amounted to +0.54 percentage points. Educational level was associated with 
annual change in CVD risk; comprehensive school or lower as highest educational level was 
associated with larger increase in CVD risk compared to high school education as well as university 
education. Smoking at baseline was associated with lower increase in CVD risk although the absolute 
CVD risk score was significantly higher for smokers at the end of the follow-up period compared to 
non-smokers. 
As the number of observations was significantly reduced for the analysis of five-year CVD risk (978 
observations) compared to the above HbA1c analysis (16,367 observations) due to missing data for 
some of the underlying risk-prediction variables, a comparative analysis of the data sets was 
performed to estimate the possible impact of missing data. There were no notable differences 
between this subpopulation and the original study population. 
 
Figure 20. Annual change in CVD risk in individuals with T1D. From research paper III [126] with 
permission from the publisher. 
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5.4 Your demographic and socioeconomic profile tells us how well you do with Type 2 Diabetes 
– results from research paper IV 
We investigated the association between sociodemographic factors and the intermediary risk 
indicators HbA1c, systolic blood pressure, LDL cholesterol, five-year CVD risk and the process 
indicator statin use, among Swedish individuals with prevalent Type 2 Diabetes. Results regarding 
blood glucose control, systolic blood pressure and LDL cholesterol level are presented below. 
HbA1c level 
Average level of HbA1c amounted to 55.1 mmol/mol. The demographic and socioeconomic factors 
studied were associated with blood glucose control also after adjustments for other relevant factors; 
women had better blood glucose control than men, and the youngest age groups showed the worst 
blood glucose control. Individuals with university education showed significantly better blood glucose 
control than individuals with high school education and comprehensive school as highest educational 
level. Origin was associated with blood glucose control; being born outside the EU was associated 
with higher HbA1c levels. Smoking at baseline was associated with higher HbA1c. 
In addition, several clinical factors were associated with levels of HbA1c; duration of diabetes, BMI 
and history of diabetes-related complications (CVD, eye disease and extremity complications) were 
all individually associated with worse blood glucose control. 
 
 
 
Figure 21. HbA1c in individuals with T2D. From research paper IV [127] with permission from the 
publisher. 
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Systolic blood pressure 
Average level of systolic blood pressure amounted to 135.7 mm Hg. Higher age was associated with 
higher systolic blood pressure whereas sex was not significantly associated with differences in levels 
of systolic blood pressure. 
Higher educational level, i.e. university education, was associated with lower systolic blood pressure 
compared to high school education and comprehensive school education. Never having been 
married was associated with higher systolic blood pressure than being married or being divorced. 
Being born in a Nordic country was associated with lower systolic blood pressure compared to being 
born in non-EU Europe (EU-27[128]), whereas it was associated with a higher systolic blood pressure 
compared to being born outside Europe. 
Clinical factors including higher LDL, higher BMI, higher eGFR and higher HbA1c were all individually 
associated with higher systolic blood pressure. Previous diagnosis of atrial fibrillation, a psychiatric 
condition or a depressive episode was associated with lower systolic blood pressure. Also, risk of 
having a systolic blood pressure above 140 mm Hg was analyzed as a dichotomous outcome, and the 
patterns were the same as in the analyses of systolic blood pressure as a continuous variable in terms 
of association with the case-mix factors included. 
 
 
Figure 22. Systolic blood pressure in individuals with T2D. From research paper IV [127] with 
permission from the publisher. 
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LDL cholesterol level 
Average level of LDL cholesterol amounted to 2.7 mmol/L. Women showed higher levels of LDL 
cholesterol than men. The youngest age group showed higher levels of LDL cholesterol compared to 
the oldest. Longer duration of diabetes and higher BMI were both individually associated with lower 
levels of LDL cholesterol, as were previous diagnosis of CVD or of atrial fibrillation. 
 
 
Figure 23. LDL cholesterol level in individuals with T2D. From research paper IV [127] with 
permission from the publisher. 
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5.5 Pre-stroke mental comorbidity is associated with what stroke care you get – results from 
research paper V 
We assessed whether individuals with a history of psychosis or schizophrenia diagnosis, registered 
prior to stroke, received different stroke care in terms of resource levels and process compared to 
other stroke patients, and whether these individuals achieved health outcomes after stroke that 
differed from other stroke patients. Explanatory variables used in multivariate regression analysis are 
presented in Table 7, and results per study outcome is presented in Table 8. 
 
Table 8. Crude and adjusted values of selected indicators for the psychosis and non-psychosis 
groups. From research paper V [129] with permission from the publisher. Adjusted values account 
for differences in case-mix factors as stated in Table 7. 
 
Pre-stroke 
psychosis 
Non-psychosis 
Unadjusted 
OR/coefficient 
(CI 95%) 
Adjusted 
OR/coefficient 
(CI 95%) 
28-day survival (%)  87.7 
(84.4; 90.9) 
89.6  
(89.3; 89.9)  
0.82 
(0.61; 1.11) 
1.07 
(0.71; 1.62) 
1-year survival (%)  74.8 
(70.5; 79.1) 
76.9 
(76.6; 77.3) 
0.89 
(0.71; 1.12) 
1.23 
(0.90; 1.68) 
1-year recurrent stroke (%)  8.6 
(5.4; 11.8) 
5.9 
(5.6; 6.1) 
1.50 
(0.99; 2.27) 
1.57 
(1.01; 2.44) 
Good 3-months functioning 
(approximated mRS 0-2, %) 
22.2 
(16.7; 27.7) 
50.6 
(50.1; 51.1) 
0.28 
(0.20; 0.38) 
0.44 
(0.29; 0.66) 
Good 1-year functioning 
(approximated mRS 0-2, %) 
 30.0 
(22.3; 37.7) 
58.1 
(57.5; 58.7) 
0.31 
(0.22; 0.44) 
0.40 
(0.24; 0.65) 
Reperfusion treatment 
(thrombolysis or 
thrombectomy, %) 
 3.4 
(1.6; 5.2) 
6.8 
(6.5; 7.0) 
0.48 
(0.28; 0.84) 
 0.53 
(0.29; 0.98) 
Endarterectomy within 14 
days 
(%) 
0.3 
(0.0; 0.8) 
1.4 
(1.3; 1.5) 
0.18 
(0.03; 1.31) 
* 
Initial inpatient stay 
(days) 
 12.8 
(11.8; 13.9) 
13.2 
(13.1; 13.3)  
-0.03 
 (-0.12; 0.69) 
-0.04 
(-0.15; 0.06) 
Inpatient care first year 
(days) 
 33.7 
(28.4; 38.9) 
20.9 
(20.6; 21.3) 
0.48 
(0.36; 0.59) 
0.32 
(0.20; 0.44) 
Inpatient care first year 
excluding at psychiatric unit 
(days) 
25.1 
(21.1; 29.2) 
20.5 
(20.2; 20.8) 
0.20 
(0.08; 0.32) 
0.06 
(-0.06; 0.19) 
Outpatient care first year 
(visits) 
 19.7 
(16.9; 22.4) 
19.2 
(19.0; 19.5) 
0.02 
(-0.09; 0.13) 
-0.01 
(-0.12; 0.11) 
Added home-help services 
(hours) 
156 
(71; 240)  
125 
(119: 130) 
30.8** 
(-33.0; 94.5)  
25.8** 
(-40.3; 91.9) 
Antihypertensive medication 
(%) 
68.7 
(63.4; 74.1) 
84.1 
(83.7; 84.5) 
0.42 
(0.32; 0.53) 
0.55 
(0.42; 0.73) 
Oral anticoagulant*** 
(%) 
40.4 
(26.6; 54.2) 
55.0 
(53.9; 56.1) 
0.55 
(0.32; 0.97) 
0.54 
(0.28; 1.03) 
*Omitted from regression model due to perfect co-linearity (sample too small) 
**Refers to mean number of added hours of home help for the psychosis group (modeled as continuous variable) 
***Proportion of subgroup with diagnosis of atrial fibrillation in the past two years 
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The subgroup of patients with history of psychosis or schizophrenia was less likely to receive 
reperfusion treatment and was less likely to report good functional outcome (approximated mRS <2) 
at three months as well as one year after stroke. Regarding secondary prevention, these patients 
showed lower levels of dispensation of drugs (antihypertensives) and had higher risk of stroke 
recurrence. Inpatient care consumption during the year after stroke was significantly higher in these 
patients although this difference was not statistically significant after exclusion of care at psychiatric 
unit. The results emphasize the importance of taking mental comorbidity into account, as it may have 
a significant impact on stroke care and its results. 
 
 
Figure 24. Distribution (crude) over approximated mRS categories for the two subgroups, at three 
months and one year. From research paper V [129] with permission from the publisher. 
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6. Conclusions and discussion 
Several health inequity gradients are present within Swedish stroke and diabetes care, and this 
knowledge is not new. Some Swedish citizens, all with universal access to healthcare, may in fact be 
worse off depending on their demographic or socioeconomic profile or their geographic residence. 
Insights are delivered and actions are taken, continuously, but we have not yet been able to adjust 
the key mechanisms and drivers of this development in a good way. 
6.1 Conclusions on Swedish stroke and diabetes care delivery – equitable or not? 
Based on registry data available there are inequities in Swedish stroke and diabetes care delivery 
today regarding health outcomes, resource use or care process. The inequities seem to be 
determined by demographics such as sex and age, by the patient’s individual socioeconomic starting 
point, or by geographic location of the treating unit. 
6.1.1 Conclusions on health equity in terms of demography, socioeconomics and geography 
As according to the perspectives described under section 1.1.1, here is a short summary on the three 
dimensions; demography, socioeconomics, and geography. 
Demography. There are differences in health regained and healthcare received. Women with 
ischemic stroke were found to have lower function (approximated modified Rankin Scale) one year 
after stroke whilst a higher proportion of women survived the first year compared to men. Inpatient 
care received (regional financing) was lower for female stroke patients whilst proportion of patients 
staying in special housing (municipal financing) was higher during the year prior to and the year after 
stroke. Women with Type 1 Diabetes had worse blood glucose control compared to men. For Type 2 
Diabetes, women had better blood glucose control compared to men, but higher levels of LDL 
cholesterol. Younger individuals typically showed worse blood glucose control than older for both 
Type 1 Diabetes and Type 2 Diabetes. 
As stroke and diabetes afflict individuals across most age groups and to a similar extent for women 
and men, there is no obvious reason to why a difference on any of these dimensions should be 
expected or, even less so, accepted. There are additional characteristics that are often closely related 
to these demographic attributes, e.g. elderly women are widowed to a larger extent than men in the 
same age and live alone to a larger extent. Important to note is however that the demographic 
differences observed was significant also after adjustments for such characteristics. 
Socioeconomics. The socioeconomic situation of individuals afflicted with stroke and/or diabetes 
also seems to play a role regarding health outcomes achieved and care process and healthcare 
resources received; high educational level (> 12 years) was a significant predictor for better blood 
glucose control in both Type 1 and Type 2 Diabetes. High educational level was also a significant 
positive predictor for survival first year after stroke and functional status first year after ischemic 
stroke (data not presented in research papers). 
The attributes related to an individual’s socioeconomic situation are several, and they are complexly 
interlinked. The effect of an individual’s social and economic context on that individual’s health has a 
pathway with several checkpoints in which the difference in effect between a “better-off” and a 
“worse-off” individual may multiply at each checkpoint (as schematically illustrated in Figure 3). 
Consequently, there are several stages along the individual’s health pathway where improvements 
can be made. Lowering the barriers for “worse-off” individuals to reduce comorbidity, to understand 
their need, to express their need (demand) in order to better access healthcare (theoretically 
speaking; minimizing the multipliers of the differences in effect along the pathway) are all promising 
ways to lower health inequity. The case with pre-stroke psychosis/schizophrenia also highlights that 
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such comorbidity along the pathway complicates the situation with regards to elements such as 
informed consent and effective rehabilitation due to e.g. social manifestations of the comorbidity 
[71, 129]. 
Geography. There is also a geographic gradient in Swedish stroke care, where a few hospitals achieve 
significantly better health outcomes than others and a few achieve significantly worse, after 
adjustments for differences in patient characteristics. Some hospitals showed significantly higher 
levels of resource use whilst other showed significantly lower levels. No clear pattern emerged 
regarding the included hospitals’ relationship between health outcomes and resource use. 
Sweden’s decentralization of decision making in healthcare to the 21 regions’ own administrations 
makes health equity a particularly relevant topic to study. Given this decentralization, geographical 
differences may appear and accelerate over time. Also, the geographical differences may drive 
differences that we instead observe as demographic or socioeconomic inequities, as the regions may 
have varying distributions of health, resources and process amongst its inhabitants. This may also 
skew the overall national distributions in different directions. 
6.1.2 Degree of health inequity depends on terms for assessment 
Given that there are significant differences in outcomes depending on individuals’ sex, age, 
socioeconomic situation and geographic place of residence, it is relevant to discuss the context of the 
assessment and its underlying terms. This can be done in accordance with the principles described 
under section 1.1.2. 
Dependency on relative versus absolute differences, and comparison to the average or best-
off group. If there was a clear cut-off point on a health status scale at which the above levels did not 
have an impact on anything with regards to life expectancy or future health-related quality of life, a 
comparison to that absolute level of health would be feasible. If it was hard to reach that level and 
seldomly done in the population, it would be more feasible to perform comparisons in relation to 
others, i.e. given that the target level is almost impossible to achieve, it makes sense to compare the 
level of health with others’. Then, the next question is whether to compare achieved health level to 
the top performers or to the average. 
As within all five research papers (I-V), the assessments have been based on relative differences 
(between subgroups of patients) and referring to the average. The reason for this approach is to 
study the healthcare system based on its actual performance and what it appears to be able to 
achieve for the population it serves. The risk with applying an absolute level of reference is that it 
may not be possible to achieve for all patients given the system’s current resources. Assessing the 
relative difference between patients is more a measure to understand how the current resources 
have been spent and whether this spending seems equitable or not. 
The extent of the individual’s responsibility of her own health is a complex topic. The dimensions of 
an individual’s responsibility are implicitly assessed within research paper III and IV (smoking and BMI 
used as predictors for health outcomes) and to some extent in research paper II (i.e. the choice of 
living in a particular region and thereby accepting its properties of healthcare organization and 
quality of care). We are continuously faced with and forced to make health trade-offs in life; the 
alternatives may sometimes be clear and sometimes not. It is important to understand that the 
clarity of alternatives may vary depending on your background. 
The maximin principle of justice or equality could be used as basis for judging whether Swedish 
stroke and diabetes care delivery is equitable or not. Based on that principle, the system should be 
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evaluated from the perspective of how well the worst-off group fares “with respect to inequality” 
[17], i.e. the results of the worst-off group compared to others. 
Then, is the worst-off group relatively well taken care of? This question is a matter of vertical equity 
[27], and something that Sweden by law aims at [4]. Given the assumption that a state’s laws reflect 
the inhabitants’ wishes on how things should work, one could say that it is the Swedish people’s wish 
that the worst-off group shall be well taken care of. The worst-off group is apparently not as well 
taken care of as the intention is and has been expressed. An objective indication of this is that 
patient characteristics, that should not play a part in determining levels of outcomes, are statistically 
significant predictors of outcomes when other relevant factors are adjusted for. Outcomes not being 
completely explained by need (in this context approximated by clinical patient characteristics), but by 
other factors such as socioeconomic status, are not the result of an equitable system [28]. 
It is also important to note that we must distinguish need from demand; demand is more easily 
measured in terms of resource use indicators but may also exceed or fall short of the individual’s 
actual need. In addition, resource use is a result of not only demand but of access. These dimensions 
may all play a part in attenuating or reinforcing health inequity gradients. 
 
6.2 Underlying mechanisms and drivers of health inequity 
The conclusion that your age, sex, socioeconomic situation or place of residence affects your chances 
to regain health or even survive may not be new or unique. Unfortunately, this pattern has 
repeatedly been proven to prevail, and the research papers included in this thesis are additional 
pieces of evidence pointing this out. It is also interesting to note that this is still the case for Sweden 
which offers universal and tax-funded care and is assumed to be one of the most equitable countries 
in the world according to e.g. comparisons of the Gini index [130]. 
The association of certain patient characteristics – e.g. socioeconomic situation – with levels of 
healthcare results and resources received has been pointed out extensively in previous research; it 
has been suggested that inequality of socioeconomics causes differences in health through several 
pathways, of which the healthcare system is only one and where the others include the social 
environment and lifestyle patterns [131]. The inequity connected with the healthcare system refers 
to what has been described as a lower likelihood of being insured and using fewer healthcare 
services [132]. In the Swedish context, assessed within this thesis, the former argument cannot be 
deemed relevant whilst the later could possibly be applicable given recent reforms in parts of the 
Swedish healthcare system [133]. Sen points out that communities can improve health status among 
its inhabitants by investing in common goods via e.g. taxation [134], and Sweden is only one example 
within this category. As access to care is universal and tax-funding covers most of the costs, there 
must be other barriers that apply to the Swedish setting. 
Several mediators of health disparities have been assessed in the literature on health inequities, and 
to enable changing of the situation and pointing out adequate actions it is essential to understand 
how the drivers of these disparities act. There are a few recurring themes in the scientific literature; 
lifestyle, e.g. physical activity and diet including alcohol consumption and tobacco use, as well as 
environmental factors including specific exposures, work situation and the social environment in 
professional and private life [40, 135]. In addition to understanding the drivers, it is important to 
apply sophisticated methods to continuously monitor their development. There are still knowledge 
gaps regarding how to go about that and take appropriate actions in order to achieve a higher degree 
of health equity. 
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6.3 Possible policy implications 
6.3.1 A theoretical context of health policy 
One explanation to the apparent health inequities highlighted in this thesis is that there is a social 
hierarchy and that the different social positions have access to different levels of resources [16], 
which lead to different levels of abilities along the treatment pathway and different levels of health 
outcomes. Consequently, a select group in general gets the advantages of progress in a field, e.g. 
thrombectomy after having had a stroke care or automated insulin pump after diagnosis with Type 1 
Diabetes. If that would be the only way to approach introduction of new interventions and 
technology, the fact that stroke and diabetes care delivery are inequitable would still possibly be 
considered fine as it may change over time; if the level of health within the most privileged group 
could be observed as the minimum level of health for the whole population at a later point in time 
[15], then systematic differences in the levels of health between groups could be considered less 
unjust (as they are temporary). During different stages of the epidemiologic transition it may be 
inevitable with temporarily present systematic disparities between groups when new ways of 
healthcare – e.g. diagnostics and treatment methods – spread across the population. Regardless, 
stroke and diabetes are two well-known conditions since many years. The fact that not all should be 
able to benefit from available treatments and available levels of health outcomes does just not sound 
right. In addition to that the conditions have been relatively common – across all socioeconomic 
groups, across all (Swedish) geographies, and for both women and men – introducing new 
techniques are not bound to such attributes but could be performed across all these categories to 
the same extent. 
The spreading of best practice within healthcare across all sociodemographic and geographic groups 
is a condition for minimizing health inequities in society. The theories presented above may be 
relevant in trying to understand the inert process of spreading interventions, resource utilization and 
health outcomes across all groups until it can be regarded as a “common good” (as it should be 
according to the UN, the EU and Swedish law). Figure 25 illustrates how the two groups (embodied 
by the two colors) for each point in time (“0”, “1”, “5”, “20”), e.g. years after introduction of a new 
intervention, experience different rates of penetration of the new intervention (embodied by the y-
axis, e.g. proportion of the diagnosed population that also has gone through the intervention, 
assuming that all patients are eligible for it and without any contraindications). The two colors could 
represent different sexes, different age groups, different socioeconomic groups or different 
geographies. A difference in penetration is then – rationally or not – explained by the time factor. 
The longer the time period, the less plausible the argument may seem to be. 
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Figure 25. Schematic overview of a fictive scenario with differing penetration speed of a new 
intervention in two different groups with the same clinical eligibility for the intervention. 
Given that acute care in general have higher degree of follow-ups and development of guidelines, it 
is not unlikely that the more chronic the condition, the more dependent on self-care, and the higher 
the number of comorbidities: the higher the degree of health inequity at any given point in time. 
6.3.2 Actions to improve the situation 
If the government and regions would want to ensure equitable healthcare delivery, there is a need to 
introduce new ways of managing population health and healthcare. 
There is a need for continuous monitoring of general as well as disease-specific indicators to 
understand how the situation of health equity is evolving. General indicators are needed to motivate 
decision makers by conveying the bigger picture, i.e. what is the actual burden to society in terms of 
health inequities and their implications now and over time. Disease-specific indicators are needed to 
understand what actions are most relevant and prioritized for the caregiving units and professional 
groups treating patients with the different conditions. Ongoing digitalization efforts should be 
designed to enhance this development. 
There is a need to translate recommendations that come out of assessment initiatives to reduce 
health inequities, into concrete action programs across regions. The key to success is probably to be 
as concrete as possible regarding identified drivers and actions needed – e.g. how to raise awareness 
of best self-treatment in Type 2 Diabetes – and to use all available and justifiable techniques for 
implementation. 
There are multiple initiatives and ongoing work by different organizational bodies that impact the 
situation of health inequities in a positive direction. Without such initiatives, the situation in terms of 
health inequity would probably be much worse. For example, the quality registries continuously 
(annually in most cases) report the development of the case mix of the patient population and the 
development of health over time. Furthermore, the National Board of Health and Welfare publishes 
clinical data that are possible to evaluate for healthcare professionals as well as the general public 
[111]. During 2018, the Swedish regions have initiated a joint system for knowledge sharing and 
steering, with support from the Swedish Association of Local Authorities and Regions (SKL). The 
purpose of this system is to enable development and spreading of best practices, with the long-term 
goal to contribute to better and more equitable healthcare [114]. These efforts altogether highlight 
the situation and makes the room for improvement publicly known. 
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6.4 Limitations, strengths and validity 
As the study populations assessed within this thesis are based on the Swedish population only, and 
as healthcare systems differ significantly between countries with regards to financing, organization 
and access for the individual, general conclusions can be applied to the Swedish setting but for other 
contexts only with caution. All five studies included within this thesis are based on registry data, and 
consequently they have several features in common. 
6.4.1 Selection bias 
Selection bias concerns the risk that the sample of the study material is not representative for the 
population intended to be studied [136]. Consequently, there would be selection bias present if the 
sources of data were not representative for stroke patients and diabetes patients in the Swedish 
population. 
The registries used in the studies of this thesis have high coverage rates with regards to the Swedish 
population; the Swedish Stroke Register and the National Diabetes Register both have a coverage 
rate estimated to more than 90% for the time periods studied [7, 80], and the regional administrative 
systems are supposed to be a complete reflection of care delivered to the inhabitants. The overall 
degree of selection bias is estimated to be small as the coverage rates of the registries used for 
inclusion of subjects are high. It is however important to note that there may be certain groups of 
patients that are systematically lost in follow-up and who for that reason are not subject to inclusion 
within the quality registries. If the extent of such systematic error is not negligibly low, the study 
populations would not reflect the general population. 
6.4.2 Information bias 
Given that the studies included are registry studies, we are dependent on that the interpretation of 
variables at registration are the same across different caregiving units and regions who report data 
on baseline characteristics and outcomes. Otherwise, there may be systematic errors in terms of 
what information is included in the reported data. The quality registries included continuously follow 
up on reporting to the registry and publishes support for registration and interpretation which are 
continuously updated [137, 138]. Such efforts should minimize the risk of significant deviations 
regarding interpretation and misunderstanding of variables from the quality registries. 
6.4.2.1 Reporting routines 
Reporting routines may vary between regions as well as between care levels. Given the national 
approach from quality registries versus the regions’ – by nature – regional routines, the risk of 
information bias is probably higher concerning regional administrative data even though the 
underlying logic is supposed to be the same, using the same versions of diagnosis (ICD-10) and 
procedure (KVÅ) codes. 
In the case of diagnosis and/or procedure registrations within primary care, it was apparent that a 
significant proportion of visits missed information on main diagnosis or procedure, which may imply 
that the correct levels of comorbidity are underestimated. This risk is probably more applicable to 
the Type 2 diabetes population (research paper IV) as these patients are cared for within primary 
care to a larger extent than individuals with T1D or stroke. 
Bias due to reporting routines is also particularly relevant regarding research paper II in which stroke 
care at different hospitals within different regions is assessed. Systematic errors and ways of 
registering and reporting may be assumed to be equally distributed over several dimensions 
including sex (research paper I) but not when assessing different caregiving units and regions, as the 
routines are probably a result of the local or regional culture. 
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6.4.2.2 Recall bias 
Recall bias appears when the reported information on e.g. disease history differs from what was 
actually the case, due to recollection back in time [136]. This applies to all research papers (I-V) in 
terms of patient-reported baseline characteristics and outcomes, and the degree of recall bias is 
probably related to the time interval between the activity and the reporting/filling out the form, as 
well as to the cognitive state of the patient (e.g. dementia in stroke patients). 
6.4.2.3 Validity of indicators selected and their underlying data 
Indicators used within the studies included in this thesis generally have high coverage rates and have 
been subject to validation in scientific studies (e.g. the acute form for registration in the Swedish 
Stroke Register [139]). There are a few indicators that pose higher risk of bias; 
• Patient-reported outcomes – these are to some extent subject to be filled in by a next of kin 
(especially for the stroke populations) rather than the patient in case the patient have 
challenges with doing it on his or her own (research papers I, II, V). 
• Approximation of modified Rankin Scale (mRS) – there is no specific mRS information in the 
Swedish Stroke Register, but a previous study [118] has validated the method of 
approximating mRS based on a number of different variables collected by the registry 
(research papers I, II, V). 
• Comorbidity – instead of selected diagnoses, inpatient care the year prior to the stroke event 
was used as a proxy and independent variable (research papers I, II, V). Comorbidity reported 
by the diabetes cohorts (research papers III, IV) may to some extent be subject to recall bias 
described above. 
• Stroke recurrence – its registration is uncertain as the routines for registering new or 
recurrent stroke may differ between caregiving units and regions. Therefore, only recurrent 
strokes registered at clinics managing acute stroke care were included (research papers I, 
II, V). 
6.4.3 Confounding 
With the various data sources available, there was a strong ability to adjust for a broad range of 
possible confounders in the analysis. In order to ensure that all possible confounders were accounted 
for, care processes for the two conditions were mapped and the data sources available were 
leveraged to identify all relevant indicators. However, there may still be residual confounding present 
that have not been accounted for during this process. Furthermore, not all relevant factors identified 
were available, including; 
• Stroke severity (NIHSS). As the coverage rate of NIHSS amounted to below 50% for included 
subjects, the variable was not used in order not to significantly reduce the size of the study 
sample. Instead, level of consciousness at arrival to hospital was used as proxy, as this 
indicator has been shown to be associated with outcomes (e.g. survival and functional status 
after discharge) [140] and as it has very high coverage in the Swedish Stroke Register. 
• Metabolic factors such as diet, physical activity and smoking. It is possible to register smoking 
in both the Swedish Stroke Register and in the National Diabetes Register, but the coverage 
rate for this variable varied in relation to the other quality registry variables used; for the 
stroke cohorts the coverage rate was significantly lower than the other case-mix factors 
included, which was not the case for the diabetes cohorts. The variable was hence not used 
for the stroke cohorts but included in adjustments for the diabetes cohorts.  
• Environmental factors such as air pollution and exposure to dangerous materials (e.g. lead), 
shown to be associated with outcomes [135]. 
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• Information on informal care such as support at home from family or spouse which would 
have added an important perspective in terms of actual resource use. 
• Data on municipality-financed healthcare (data on region-financed healthcare and 
municipality-financed home-help services were available). 
Post-hoc corrections to account for the multiple tests performed within the studies were not 
consistently done. Such corrections can be of value in order to adjust the level of statistical 
significance for the results when the number of study outcomes is high (research papers I, II, V). In 
research paper I, the results from a Bonferroni correction was presented and showed that all 
differences found after multivariate adjustments were still significant except for one (initial inpatient 
stay in ICH patients). In the diabetes studies (research papers III and IV) the need for post-hoc 
correction is not considered warranted given the lower number of study outcomes (three in research 
paper III and five in research paper IV). 
 
6.5 Topics for future research 
Personalization of diabetes care. As many sociodemographic determinants are associated with 
health outcomes in diabetes patients, it should be highly prioritized to assess different ways of 
reducing that gradient with variants of personalized treatment regimes, evaluated in a controlled 
research setting. 
Randomized clinical trial of an updated care process and its impact on health equity, e.g. stroke 
patients with history of psychosis or schizophrenia, to enable evaluation of new ways of working to 
reduce inequities along the treatment pathway. 
Studying the age at disease onset as a determinant for health (e.g. time after stroke event, duration 
of diabetes). To deepen the understanding of the value of primary prevention, it would be interesting 
to study the association of long-term health outcomes and the individuals’ age at disease onset. 
Compliance to pharmaceutical treatment in stroke patients with history of mental comorbidity. 
Patients with pre-stroke psychosis seem to need additional support for enhancing compliance to 
pharmaceutical treatment, regardless of the cause of its lower levels compared to other stroke 
patients (i.e. a lower frequency of prescriptions, a lower compliance in filling the prescriptions, or a 
combination of both). The drivers of these differences need further assessment and was not 
addressed in research paper V as Prescribed Drug Registry data extracts do not cover prescriptions 
that have not been filled. 
Distribution of somatic illness between sexes in patient populations with mental illness. As 
concluded within research paper V, an inverse relationship in the sex distribution of stroke patients 
with previous diagnosis of psychosis or schizophrenia was found; psychosis and schizophrenia are 
more common in men, but women were overrepresented in the sample of stroke patients studied 
[60] [129]. This pattern needs to be better understood. 
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Appendix A 
 
Search string for previous research on health equity and stroke on PubMed 
 stroke[Title/Abstract] 
AND 
((((((((((equity[Title/Abstract]) OR equality[Title/Abstract]) OR disparity[Title/Abstract]) OR 
disparities[Title/Abstract]) OR difference[Title/Abstract]))) OR variation[Title/Abstract])) OR 
determinant[Title/Abstract]) OR predictor[Title/Abstract]  
AND (register[Title/Abstract]) OR registry[Title/Abstract] 
AND Sweden [Title/Abstract] OR Swedish [Title/Abstract] 
 
 
Search string for previous research on health equity and diabetes on PubMed 
 diabetes[Title/Abstract] 
AND 
((((((((((equity[Title/Abstract]) OR equality[Title/Abstract]) OR disparity[Title/Abstract]) OR 
disparities[Title/Abstract]) OR difference[Title/Abstract]))) OR variation[Title/Abstract])) OR 
determinant[Title/Abstract]) OR predictor[Title/Abstract] 
AND (register[Title/Abstract]) OR registry[Title/Abstract] 
AND Sweden [Title/Abstract] OR Swedish [Title/Abstract] 
 
 
